BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kolonin MG, Saha PK, Chan L, Pasqualini R, Arap W. Reversal of obesity by targeted ablation of adipose tissue. Nat Med. 2004;10:625-632. [PMID: 15133506 DOI: 10.1038/nm1048] [Cited by in Crossref: 423] [Cited by in F6Publishing: 434] [Article Influence: 22.3] [Reference Citation Analysis]
Number Citing Articles
1 Jirwankar Y, Dighe V. Identification and validation of Sertoli cell homing peptides as molecular steering for testis targeted drug delivery. J Drug Target 2023;:1-12. [PMID: 36604336 DOI: 10.1080/1061186X.2022.2164007] [Reference Citation Analysis]
2 Zhou J, Chen X, Chen Q, Pan B, Lou J, Jia Z, Du Y, Xu W, Zhang L, Feng X, Jin L, Shi M, Li X, Huang Z, Sun J. Novel Muscle-Homing Peptide FGF1 Conjugate Based on AlphaFold for Type 2 Diabetes Mellitus. ACS Appl Mater Interfaces 2023. [PMID: 36625595 DOI: 10.1021/acsami.2c18461] [Reference Citation Analysis]
3 Chen K, Cheong LY, Gao Y, Zhang Y, Feng T, Wang Q, Jin L, Honoré E, Lam KSL, Wang W, Hui X, Xu A. Adipose-targeted triiodothyronine therapy counteracts obesity-related metabolic complications and atherosclerosis with negligible side effects. Nat Commun 2022;13:7838. [PMID: 36539421 DOI: 10.1038/s41467-022-35470-4] [Reference Citation Analysis]
4 Yan J, Wang Y, Mu Z, Han X, Bi L, Wang X, Song P, Kang Y, Wang L, Zhang X, Wang Y, Zhang H. Gold Nanobipyramid-Mediated Apoptotic Camouflage of Adipocytes for Obesity Immunotherapy. Adv Mater 2022;:e2207686. [PMID: 36502507 DOI: 10.1002/adma.202207686] [Reference Citation Analysis]
5 Bae JS, Abueva CDG, Park GH, Kim S, Mo J, Ryu HS, Chung P, Woo SH. Electrochemical lipolysis of subcutaneous adipose tissue in a porcine animal model. Lasers Surg Med 2022. [DOI: 10.1002/lsm.23621] [Reference Citation Analysis]
6 Balcazar N, Escobar E, Fernandez M, Echeverri LF, Acin S, Muñoz DL, Orozco J. Functionalized nanoformulation based on enriched-triterpenes fraction target adipose tissue, as a potential treatment to obesity and type-2 diabetes: preliminary data. GA – 70th Annual Meeting 2022 2022. [DOI: 10.1055/s-0042-1759357] [Reference Citation Analysis]
7 Liao ZZ, Ran L, Qi XY, Wang YD, Wang YY, Yang J, Liu JH, Xiao XH. Adipose endothelial cells mastering adipose tissues metabolic fate. Adipocyte 2022;11:108-19. [PMID: 35067158 DOI: 10.1080/21623945.2022.2028372] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Cheng L, Hu J, Zhang L, Shen N, Chen H, Zhang F. Repurposing Lenvatinib as A Potential Therapeutic Agent against Thyroid Eye Disease by Suppressing Adipogenesis in Orbital Adipose Tissues. Pharmaceuticals 2022;15:1305. [DOI: 10.3390/ph15111305] [Reference Citation Analysis]
9 Sibuyi NRS, Moabelo KL, Meyer S, Skepu A, Onani MO, Madiehe AM, Meyer M. Nanotechnology-Based Strategies for Treatment of Obesity, Cancer and Anti-microbial Resistance: Highlights of the Department of Science and Innovation/Mintek Nanotechnology Innovation Centre Biolabels Research Node at the University of the Western Cape. Applied Sciences 2022;12:10512. [DOI: 10.3390/app122010512] [Reference Citation Analysis]
10 De Cena GL, Scavassa BV, Conceição K. In Silico Prediction of Anti-Infective and Cell-Penetrating Peptides from Thalassophryne nattereri Natterin Toxins. Pharmaceuticals 2022;15:1141. [DOI: 10.3390/ph15091141] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Su Y, Wang W, Xiao Q, Tang L, Wang T, Xie M, Su Y. Macrophage membrane-camouflaged lipoprotein nanoparticles for effective obesity treatment based on a sustainable self-reinforcement strategy. Acta Biomaterialia 2022. [DOI: 10.1016/j.actbio.2022.08.055] [Reference Citation Analysis]
12 Daquinag AC, Gao Z, Yu Y, Kolonin MG. Endothelial TrkA coordinates vascularization and innervation in thermogenic adipose tissue and can be targeted to control metabolism. Mol Metab 2022;63:101544. [PMID: 35835372 DOI: 10.1016/j.molmet.2022.101544] [Reference Citation Analysis]
13 Li J, Duan H, Liu Y, Wang L, Zhou X. Biomaterial-Based Therapeutic Strategies for Obesity and Its Comorbidities. Pharmaceutics 2022;14:1445. [DOI: 10.3390/pharmaceutics14071445] [Reference Citation Analysis]
14 Orr A, Liu K, Mullick AE, Huang X, Watts SW. Divergence of Chemerin Reduction by an ATS9R Nanoparticle Targeting Adipose Tissue In Vitro vs. In Vivo in the Rat. Biomedicines 2022;10:1635. [DOI: 10.3390/biomedicines10071635] [Reference Citation Analysis]
15 Rupert JE, Kolonin MG. Fatty acid translocase: a culprit of lipid metabolism dysfunction in disease. Immunometabolism 2022;4:e00001. [DOI: 10.1097/in9.0000000000000001] [Reference Citation Analysis]
16 Zhang Q, Olberg A, Sioud M. Structural Requirements for the Binding of a Peptide to Prohibitins on the Cell Surface of Monocytes/Macrophages. Int J Mol Sci 2022;23:4282. [PMID: 35457098 DOI: 10.3390/ijms23084282] [Reference Citation Analysis]
17 Boutagy NE, Singh AK, Sessa WC. Targeting the vasculature in cardiometabolic disease. J Clin Invest 2022;132:e148556. [PMID: 35289308 DOI: 10.1172/JCI148556] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
18 Zaiki Y, Lim LY, Wong TW. Critical material designs for mucus- and mucosa-penetrating oral insulin nanoparticle development. International Materials Reviews. [DOI: 10.1080/09506608.2022.2040293] [Reference Citation Analysis]
19 Zan P, Than A, Zhang W, Cai HX, Zhao W, Chen P. Transdermal Photothermal-Pharmacotherapy to Remodel Adipose Tissue for Obesity and Metabolic Disorders. ACS Nano 2022;16:1813-25. [PMID: 34979079 DOI: 10.1021/acsnano.1c06410] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
20 Chen J, Chung JY, Fang H, Lin L, Kim Y, Tian H, Chen X. Metformin booster adipocyte-targeted gene therapy for the treatment of obesity and related metabolic syndromes. Sci China Chem . [DOI: 10.1007/s11426-021-1185-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Hebbar N, Epperly R, Vaidya A, Thanekar U, Moore SE, Umeda M, Ma J, Patil SL, Langfitt D, Huang S, Cheng C, Klco JM, Gottschalk S, Velasquez MP. CAR T cells redirected to cell surface GRP78 display robust anti-acute myeloid leukemia activity and do not target hematopoietic progenitor cells. Nat Commun 2022;13. [DOI: 10.1038/s41467-022-28243-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
22 Smith TL, Sidman RL, Arap W, Pasqualini R. Targeting vascular zip codes. The Vasculome 2022. [DOI: 10.1016/b978-0-12-822546-2.25001-6] [Reference Citation Analysis]
23 Sawaguchi Y, Hirata K, Suzuki R, Maruyama K, Utoguchi N. Anti-Obesity Dendritic Cell Vaccine Therapy Targeting Neovascular Vessels in High-Fat-Diet-Fed Mice. BPB Reports 2022;5:95-98. [DOI: 10.1248/bpbreports.5.5_95] [Reference Citation Analysis]
24 Nanjappan SK, Surendran S, Paul D. Pharmacokinetics and pharmacodynamics of peptidomimetics. Peptide and Peptidomimetic Therapeutics 2022. [DOI: 10.1016/b978-0-12-820141-1.00014-5] [Reference Citation Analysis]
25 Belser M, Walker DW. Role of Prohibitins in Aging and Therapeutic Potential Against Age-Related Diseases. Front Genet 2021;12:714228. [PMID: 34868199 DOI: 10.3389/fgene.2021.714228] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
26 Ioannidou A, Fisher RM, Hagberg CE. The multifaceted roles of the adipose tissue vasculature. Obes Rev 2021;:e13403. [PMID: 34866318 DOI: 10.1111/obr.13403] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
27 Sibuyi NRS, Moabelo KL, Fadaka AO, Meyer S, Onani MO, Madiehe AM, Meyer M. Multifunctional Gold Nanoparticles for Improved Diagnostic and Therapeutic Applications: A Review. Nanoscale Res Lett 2021;16:174. [PMID: 34866165 DOI: 10.1186/s11671-021-03632-w] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
28 Zhang S, Dong Y, Wang Y, Sun W, Wei M, Yuan L, Yang G. Selective Encapsulation of Therapeutic mRNA in Engineered Extracellular Vesicles by DNA Aptamer. Nano Lett 2021;21:8563-70. [PMID: 34647460 DOI: 10.1021/acs.nanolett.1c01817] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
29 Angelidi AM, Belanger MJ, Kokkinos A, Koliaki CC, Mantzoros CS. Novel Non-invasive Approaches to the Treatment of Obesity: From Pharmacotherapy to Gene Therapy. Endocr Rev 2021:bnab034. [PMID: 34698815 DOI: 10.1210/endrev/bnab034] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
30 Kusudo T, Okada T, Hashimoto M, Takeuchi T, Endo Y, Niwa A, Yamashita H. CREG1 administration stimulates BAT thermogenesis and improves diet-induced obesity in mice. J Biochem 2021:mvab106. [PMID: 34647124 DOI: 10.1093/jb/mvab106] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
31 Pompeia C, Frare EO, Peigneur S, Tytgat J, da Silva ÁP, de Oliveira EB, Pereira A, Kerkis I, Kolonin MG. Synthetic polypeptide crotamine: characterization as a myotoxin and as a target of combinatorial peptides. J Mol Med (Berl) 2021. [PMID: 34643765 DOI: 10.1007/s00109-021-02140-9] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
32 Hennigs JK, Matuszcak C, Trepel M, Körbelin J. Vascular Endothelial Cells: Heterogeneity and Targeting Approaches. Cells 2021;10:2712. [PMID: 34685692 DOI: 10.3390/cells10102712] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 6.5] [Reference Citation Analysis]
33 Han S, Jung M, Kim AS, Lee DY, Cha BH, Putnam CW, Lim KS, Bull DA, Won YW. Peptide Adjuvant to Invigorate Cytolytic Activity of NK Cells in an Obese Mouse Cancer Model. Pharmaceutics 2021;13:1279. [PMID: 34452238 DOI: 10.3390/pharmaceutics13081279] [Reference Citation Analysis]
34 Kim IS, Yang WS, Kim CH. Beneficial Effects of Soybean-Derived Bioactive Peptides. Int J Mol Sci 2021;22:8570. [PMID: 34445273 DOI: 10.3390/ijms22168570] [Cited by in Crossref: 13] [Cited by in F6Publishing: 18] [Article Influence: 6.5] [Reference Citation Analysis]
35 da Silva Rosa SC, Liu M, Sweeney G. Adiponectin Synthesis, Secretion and Extravasation from Circulation to Interstitial Space. Physiology (Bethesda) 2021;36:134-49. [PMID: 33904786 DOI: 10.1152/physiol.00031.2020] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
36 Chen R, Huang S, Lin T, Ma H, Shan W, Duan F, Lv J, Zhang J, Ren L, Nie L. Photoacoustic molecular imaging-escorted adipose photodynamic-browning synergy for fighting obesity with virus-like complexes. Nat Nanotechnol 2021;16:455-65. [PMID: 33526836 DOI: 10.1038/s41565-020-00844-6] [Cited by in Crossref: 56] [Cited by in F6Publishing: 56] [Article Influence: 28.0] [Reference Citation Analysis]
37 Grigonyte AM, Hapeshi A, Constantinidou C, Millard A. Modification of Bacteriophages to Increase Their Association with Lung Epithelium Cells In Vitro. Pharmaceuticals (Basel) 2021;14:308. [PMID: 33915737 DOI: 10.3390/ph14040308] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
38 Huang F, Ye X, Wang Z, Ding Y, Cai X, Yu L, Waseem M, Abbas F, Ashraf U, Chen X, Ke Y. The prohibitins (PHB) gene family in tomato: Bioinformatic identification and expression analysis under abiotic and phytohormone stresses. GM Crops Food 2021;:1-16. [PMID: 33678114 DOI: 10.1080/21645698.2021.1872333] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
39 Kondrashina A, Heffernan S, O’brien N, Giblin L. Application in medicine: obesity and satiety control. Biologically Active Peptides 2021. [DOI: 10.1016/b978-0-12-821389-6.00005-4] [Reference Citation Analysis]
40 Wang X, Wang Y, Song Z, Hu X, Wei J, Zhang J, Wang H. Recent progress in functional peptides designed for tumor-targeted imaging and therapy. J Mater Chem C 2021;9:3749-72. [DOI: 10.1039/d0tc05405d] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
41 Onogi Y, Khalil AEMM, Ussar S. Identification and characterization of adipose surface epitopes. Biochem J 2020;477:2509-41. [PMID: 32648930 DOI: 10.1042/BCJ20190462] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
42 Romanelli SM, MacDougald OA. Viral and Nonviral Transfer of Genetic Materials to Adipose Tissues: Toward a Gold Standard Approach. Diabetes 2020;69:2581-8. [PMID: 33219099 DOI: 10.2337/dbi20-0036] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
43 Scheja L, Heeren J. Novel Adipose Tissue Targets to Prevent and Treat Atherosclerosis. Handb Exp Pharmacol 2020. [PMID: 33373032 DOI: 10.1007/164_2020_363] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
44 Hiradate R, Khalil IA, Matsuda A, Sasaki M, Hida K, Harashima H. A novel dual-targeted rosiglitazone-loaded nanoparticle for the prevention of diet-induced obesity via the browning of white adipose tissue. J Control Release 2021;329:665-75. [PMID: 33038450 DOI: 10.1016/j.jconrel.2020.10.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
45 Sharma G, Hu C, Staquicini DI, Brigman JL, Liu M, Mauvais-Jarvis F, Pasqualini R, Arap W, Arterburn JB, Hathaway HJ, Prossnitz ER. Preclinical efficacy of the GPER-selective agonist G-1 in mouse models of obesity and diabetes. Sci Transl Med 2020;12:eaau5956. [PMID: 31996464 DOI: 10.1126/scitranslmed.aau5956] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 13.3] [Reference Citation Analysis]
46 Watanabe E, Wada T, Okekawa A, Kitamura F, Komatsu G, Onogi Y, Yamamoto S, Sasahara M, Kitada M, Koya D, Tsuneki H, Sasaoka T. Stromal cell-derived factor 1 (SDF1) attenuates platelet-derived growth factor-B (PDGF-B)-induced vascular remodeling for adipose tissue expansion in obesity. Angiogenesis 2020;23:667-84. [PMID: 32699964 DOI: 10.1007/s10456-020-09738-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
47 Fang Y, Kaszuba T, Imoukhuede PI. Systems Biology Will Direct Vascular-Targeted Therapy for Obesity. Front Physiol 2020;11:831. [PMID: 32760294 DOI: 10.3389/fphys.2020.00831] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
48 Indu S, Kaliappan KP. Synthetic approaches towards cortistatins: evolution and progress through its ages. Org Biomol Chem 2020;18:3965-95. [PMID: 32420567 DOI: 10.1039/d0ob00770f] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
49 Yamashita Y, Takeuchi T, Endo Y, Goto A, Sakaki S, Yamaguchi Y, Takenaka H, Yamashita H. Dietary Supplementation with Dunaliella Tertiolecta Prevents Whitening of Brown Fat and Controls Diet-Induced Obesity at Thermoneutrality in Mice. Nutrients 2020;12:E1686. [PMID: 32516922 DOI: 10.3390/nu12061686] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
50 Banerjee A, Sharma D, Trivedi R, Singh J. Treatment of insulin resistance in obesity-associated type 2 diabetes mellitus through adiponectin gene therapy. Int J Pharm 2020;583:119357. [PMID: 32334065 DOI: 10.1016/j.ijpharm.2020.119357] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
51 Eckel-Mahan K, Ribas Latre A, Kolonin MG. Adipose Stromal Cell Expansion and Exhaustion: Mechanisms and Consequences. Cells 2020;9:E863. [PMID: 32252348 DOI: 10.3390/cells9040863] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
52 Indu S, Telore RD, Kaliappan KP. Construction of key building blocks towards the synthesis of cortistatins. Org Biomol Chem 2020;18:2432-46. [PMID: 32163085 DOI: 10.1039/d0ob00170h] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
53 Nijhawans P, Behl T, Bhardwaj S. Angiogenesis in obesity. Biomed Pharmacother 2020;126:110103. [PMID: 32200253 DOI: 10.1016/j.biopha.2020.110103] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
54 Fang CH, Lin YT, Liang CM, Liang SM. A novel c-Kit/phospho-prohibitin axis enhances ovarian cancer stemness and chemoresistance via Notch3-PBX1 and β-catenin-ABCG2 signaling. J Biomed Sci 2020;27:42. [PMID: 32169072 DOI: 10.1186/s12929-020-00638-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
55 Chung JY, Ain QU, Song Y, Yong SB, Kim YH. Targeted delivery of CRISPR interference system against Fabp4 to white adipocytes ameliorates obesity, inflammation, hepatic steatosis, and insulin resistance. Genome Res 2019;29:1442-52. [PMID: 31467027 DOI: 10.1101/gr.246900.118] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 11.7] [Reference Citation Analysis]
56 Barbier-Torres L, Lu SC. Prohibitin 1 in liver injury and cancer. Exp Biol Med (Maywood) 2020;245:385-94. [PMID: 32077311 DOI: 10.1177/1535370220908257] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
57 Hutchison DM, Hakimi AA, Hong EM, Pham TT, Wijayaweera A, Seo S, Qu Y, Bircan M, Sivoraphonh R, Dunn B, Sun CH, Kobayashi MR, Kim S, Wong BJF. Electrochemolipolysis of Human Adipose Tissue. Facial Plast Surg Aesthet Med 2020;22:86-92. [PMID: 32078388 DOI: 10.1089/fpsam.2019.29011.hut] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
58 Wang D, Tabti R, Elderwish S, Abou-Hamdan H, Djehal A, Yu P, Yurugi H, Rajalingam K, Nebigil CG, Désaubry L. Prohibitin ligands: a growing armamentarium to tackle cancers, osteoporosis, inflammatory, cardiac and neurological diseases. Cell Mol Life Sci 2020;77:3525-46. [PMID: 32062751 DOI: 10.1007/s00018-020-03475-1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
59 Onogi Y, Wada T, Okekawa A, Matsuzawa T, Watanabe E, Ikeda K, Nakano M, Kitada M, Koya D, Tsuneki H, Sasaoka T. Pro-inflammatory macrophages coupled with glycolysis remodel adipose vasculature by producing platelet-derived growth factor-B in obesity. Sci Rep 2020;10:670. [PMID: 31959796 DOI: 10.1038/s41598-019-57368-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
60 Al-khater KM, Al-suhaimi EA. Application of Nanomaterials in Treatment of Endocrine Diseases. Applications of Nanomaterials in Human Health 2020. [DOI: 10.1007/978-981-15-4802-4_10] [Reference Citation Analysis]
61 Sibuyi NRS, Moabelo KL, Meyer M, Onani MO, Dube A, Madiehe AM. Nanotechnology advances towards development of targeted-treatment for obesity. J Nanobiotechnology 2019;17:122. [PMID: 31842876 DOI: 10.1186/s12951-019-0554-3] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 5.8] [Reference Citation Analysis]
62 Bauknight DK, Osinski V, Dasa SSK, Nguyen AT, Marshall MA, Hartman J, Harms M, O'Mahony G, Boucher J, Klibanov AL, McNamara CA, Kelly KA. Importance of thorough tissue and cellular level characterization of targeted drugs in the evaluation of pharmacodynamic effects. PLoS One 2019;14:e0224917. [PMID: 31725756 DOI: 10.1371/journal.pone.0224917] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
63 Ju N, Shimamura M, Hayashi H, Ikeda Y, Yoshida S, Nakamura A, Morishita R, Rakugi H, Nakagami H. Preventative effects of the partial RANKL peptide MHP1-AcN in a mouse model of imiquimod-induced psoriasis. Sci Rep 2019;9:15434. [PMID: 31659208 DOI: 10.1038/s41598-019-51681-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
64 Rajabi M, Adeyeye M, Mousa SA. Peptide-Conjugated Nanoparticles as Targeted Anti-angiogenesis Therapeutic and Diagnostic in Cancer. CMC 2019;26:5664-83. [DOI: 10.2174/0929867326666190620100800] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
65 Peng M, Wang XQ, Zhang Y, Li CX, Zhang M, Cheng H, Zhang XZ. Mitochondria-Targeting Thermosensitive Initiator with Enhanced Anticancer Efficiency. ACS Appl Bio Mater 2019;2:4656-66. [PMID: 35021424 DOI: 10.1021/acsabm.9b00739] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
66 Li J, Cha R, Luo H, Hao W, Zhang Y, Jiang X. Nanomaterials for the theranostics of obesity. Biomaterials 2019;223:119474. [PMID: 31536920 DOI: 10.1016/j.biomaterials.2019.119474] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
67 Park J, Kim HL, Jung Y, Ahn KS, Kwak HJ, Um JY. Bitter Orange (Citrus aurantium Linné) Improves Obesity by Regulating Adipogenesis and Thermogenesis through AMPK Activation. Nutrients 2019;11:E1988. [PMID: 31443565 DOI: 10.3390/nu11091988] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 5.5] [Reference Citation Analysis]
68 Rosa-Gonçalves P, Majerowicz D. Pharmacotherapy of Obesity: Limits and Perspectives. Am J Cardiovasc Drugs 2019;19:349-64. [PMID: 30793263 DOI: 10.1007/s40256-019-00328-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
69 Zhang Y, Zhao W, Xu H, Hu M, Guo X, Jia W, Liu G, Li J, Cui P, Lager S, Sferruzzi-Perri AN, Li W, Wu XK, Han Y, Brännström M, Shao LR, Billig H. Hyperandrogenism and insulin resistance-induced fetal loss: evidence for placental mitochondrial abnormalities and elevated reactive oxygen species production in pregnant rats that mimic the clinical features of polycystic ovary syndrome. J Physiol 2019;597:3927-50. [PMID: 31206177 DOI: 10.1113/JP277879] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 7.8] [Reference Citation Analysis]
70 Ash GI, Kim D, Choudhury M. Promises of Nanotherapeutics in Obesity. Trends Endocrinol Metab 2019;30:369-83. [PMID: 31126754 DOI: 10.1016/j.tem.2019.04.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
71 Yahiro K, Ogura K, Terasaki Y, Satoh M, Miyagi S, Terasaki M, Yamasaki E, Moss J. Cholix toxin, an eukaryotic elongation factor 2 ADP-ribosyltransferase, interacts with Prohibitins and induces apoptosis with mitochondrial dysfunction in human hepatocytes. Cell Microbiol 2019;21:e13033. [PMID: 31009148 DOI: 10.1111/cmi.13033] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
72 Glukhov AI, Gryzunova GK, Usai LI, Aleynikova TL, Chernikova NV, Burt AY. The Role of Apoptosis in the Pathogenic Mechanism of Critical States (Review). Obŝaâ reanimatologiâ 2019;15:79-98. [DOI: 10.15360/1813-9779-2019-2-79-98] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
73 Kumar MS. Peptides and Peptidomimetics as Potential Antiobesity Agents: Overview of Current Status. Front Nutr 2019;6:11. [PMID: 30834248 DOI: 10.3389/fnut.2019.00011] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 6.5] [Reference Citation Analysis]
74 Cruz-Bustos T, Ibarrola-Vannucci AK, Díaz-Lozano I, Ramírez JL, Osuna A. Characterization and functionality of two members of the SPFH protein superfamily, prohibitin 1 and 2 in Leishmania major. Parasit Vectors 2018;11:622. [PMID: 30514373 DOI: 10.1186/s13071-018-3195-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
75 Sibuyi NRS, Meyer M, Onani MO, Skepu A, Madiehe AM. Vascular targeted nanotherapeutic approach for obesity treatment. Int J Nanomedicine 2018;13:7915-29. [PMID: 30538468 DOI: 10.2147/IJN.S173424] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
76 Guan D, Mi J, Chen X, Wu Y, Yao Y, Wang L, Xiao Z, Zhao Y, Chen B, Dai J. Lung endothelial cell-targeted peptide-guided bFGF promotes the regeneration after radiation induced lung injury. Biomaterials 2018;184:10-9. [DOI: 10.1016/j.biomaterials.2018.08.061] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 4.2] [Reference Citation Analysis]
77 Diatlova AS, Dudkov AV, Linkova NS, Khavinson VK. Molecular Markers of Caspase-Dependent and Mitochondrial Apoptosis: Role in the Development of Pathology and Cellular Senescence. Biol Bull Rev 2018;8:472-481. [DOI: 10.1134/s2079086418060038] [Reference Citation Analysis]
78 Andrieu J, Re F, Russo L, Nicotra F. Phage-displayed peptides targeting specific tissues and organs. Journal of Drug Targeting 2019;27:555-65. [DOI: 10.1080/1061186x.2018.1531419] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
79 Hu Q, Chen X, Liu J, Di W, Lv S, Tang L, Ding G. Targeted Molecular Magnetic Resonance Imaging Detects Brown Adipose Tissue with Ultrasmall Superparamagnetic Iron Oxide. Biomed Res Int 2018;2018:3619548. [PMID: 30406134 DOI: 10.1155/2018/3619548] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
80 Nugroho DB, Ikeda K, Kajimoto K, Hirata K, Emoto N. Activation of neuregulin-4 in adipocytes improves metabolic health by enhancing adipose tissue angiogenesis. Biochemical and Biophysical Research Communications 2018;504:427-33. [DOI: 10.1016/j.bbrc.2018.08.197] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
81 Coclite A, Pascazio G, de Tullio M, Decuzzi P. Predicting the vascular adhesion of deformable drug carriers in narrow capillaries traversed by blood cells. Journal of Fluids and Structures 2018;82:638-50. [DOI: 10.1016/j.jfluidstructs.2018.08.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
82 Graupera M, Claret M. Endothelial Cells: New Players in Obesity and Related Metabolic Disorders. Trends Endocrinol Metab 2018;29:781-94. [PMID: 30266200 DOI: 10.1016/j.tem.2018.09.003] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 7.2] [Reference Citation Analysis]
83 Buehler U, Schulenburg K, Yurugi H, Šolman M, Abankwa D, Ulges A, Tenzer S, Bopp T, Thiede B, Zipp F, Rajalingam K. Targeting prohibitins at the cell surface prevents Th17-mediated autoimmunity. EMBO J 2018;37:e99429. [PMID: 30049713 DOI: 10.15252/embj.201899429] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
84 Niklowitz P, Rothermel J, Lass N, Barth A, Reinehr T. Link between chemerin, central obesity, and parameters of the Metabolic Syndrome: findings from a longitudinal study in obese children participating in a lifestyle intervention. Int J Obes 2018;42:1743-52. [DOI: 10.1038/s41366-018-0157-3] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 6.8] [Reference Citation Analysis]
85 Payab M, Goodarzi P, Foroughi Heravani N, Hadavandkhani M, Zarei Z, Falahzadeh K, Larijani B, Rahim F, Arjmand B. Stem Cell and Obesity: Current State and Future Perspective. In: Turksen K, editor. Cell Biology and Translational Medicine, Volume 2. Cham: Springer International Publishing; 2018. pp. 1-22. [DOI: 10.1007/5584_2018_227] [Cited by in Crossref: 25] [Cited by in F6Publishing: 29] [Article Influence: 5.0] [Reference Citation Analysis]
86 Spicer CD, Jumeaux C, Gupta B, Stevens MM. Peptide and protein nanoparticle conjugates: versatile platforms for biomedical applications. Chem Soc Rev 2018;47:3574-620. [PMID: 29479622 DOI: 10.1039/c7cs00877e] [Cited by in Crossref: 256] [Cited by in F6Publishing: 262] [Article Influence: 51.2] [Reference Citation Analysis]
87 Tortelli TC Junior, de Godoy LMF, de Souza GA, Bonatto D, Otake AH, de Freitas Saito R, Rosa JC, Greene LJ, Chammas R. Accumulation of prohibitin is a common cellular response to different stressing stimuli and protects melanoma cells from ER stress and chemotherapy-induced cell death. Oncotarget 2017;8:43114-29. [PMID: 28562344 DOI: 10.18632/oncotarget.17810] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
88 D'Angelo S, Staquicini FI, Ferrara F, Staquicini DI, Sharma G, Tarleton CA, Nguyen H, Naranjo LA, Sidman RL, Arap W, Bradbury AR, Pasqualini R. Selection of phage-displayed accessible recombinant targeted antibodies (SPARTA): methodology and applications. JCI Insight 2018;3:98305. [PMID: 29720567 DOI: 10.1172/jci.insight.98305] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
89 Gustafson HH, Olshefsky A, Sylvestre M, Sellers DL, Pun SH. Current state of in vivo panning technologies: Designing specificity and affinity into the future of drug targeting. Adv Drug Deliv Rev 2018;130:39-49. [PMID: 29964079 DOI: 10.1016/j.addr.2018.06.015] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
90 Thovhogi N, Sibuyi NRS, Onani MO, Meyer M, Madiehe AM. Peptide-functionalized quantum dots for potential applications in the imaging and treatment of obesity. Int J Nanomedicine 2018;13:2551-9. [PMID: 29731630 DOI: 10.2147/IJN.S158687] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
91 Lengyel E, Makowski L, DiGiovanni J, Kolonin MG. Cancer as a Matter of Fat: The Crosstalk between Adipose Tissue and Tumors. Trends Cancer 2018;4:374-84. [PMID: 29709261 DOI: 10.1016/j.trecan.2018.03.004] [Cited by in Crossref: 201] [Cited by in F6Publishing: 173] [Article Influence: 40.2] [Reference Citation Analysis]
92 Zhang Y, Yu J, Qiang L, Gu Z. Nanomedicine for obesity treatment. Sci China Life Sci 2018;61:373-9. [PMID: 29623548 DOI: 10.1007/s11427-017-9257-1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 3.4] [Reference Citation Analysis]
93 Nagaoka S. Structure-function properties of hypolipidemic peptides. J Food Biochem 2019;43:e12539. [PMID: 31353491 DOI: 10.1111/jfbc.12539] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 6.0] [Reference Citation Analysis]
94 Alsaggar M, Liu D. Organ-based drug delivery. J Drug Target 2018;26:385-97. [PMID: 29419330 DOI: 10.1080/1061186X.2018.1437919] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 3.6] [Reference Citation Analysis]
95 Kajimoto K, Katsumi T, Nakamura T, Kataoka M, Harashima H. Liposome Microencapsulation for the Surface Modification and Improved Entrapment of Cytochrome c for Targeted Delivery. J Am Oil Chem Soc 2018;95:101-9. [DOI: 10.1002/aocs.12026] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
96 Barrett EJ, Liu Z, Khamaisi M, King GL, Klein R, Klein BEK, Hughes TM, Craft S, Freedman BI, Bowden DW, Vinik AI, Casellini CM. Diabetic Microvascular Disease: An Endocrine Society Scientific Statement. J Clin Endocrinol Metab 2017;102:4343-410. [PMID: 29126250 DOI: 10.1210/jc.2017-01922] [Cited by in Crossref: 210] [Cited by in F6Publishing: 227] [Article Influence: 35.0] [Reference Citation Analysis]
97 Staquicini DI, D'Angelo S, Ferrara F, Karjalainen K, Sharma G, Smith TL, Tarleton CA, Jaalouk DE, Kuniyasu A, Baze WB, Chaffee BK, Hanley PW, Barnhart KF, Koivunen E, Marchiò S, Sidman RL, Cortes JE, Kantarjian HM, Arap W, Pasqualini R. Therapeutic targeting of membrane-associated GRP78 in leukemia and lymphoma: preclinical efficacy in vitro and formal toxicity study of BMTP-78 in rodents and primates. Pharmacogenomics J 2018;18:436-43. [PMID: 29205207 DOI: 10.1038/tpj.2017.46] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
98 Lee JH, Jeong HS, Lee DH, Beack S, Kim T, Lee GH, Park WC, Kim C, Kim KS, Hahn SK. Targeted Hyaluronate-Hollow Gold Nanosphere Conjugate for Anti-Obesity Photothermal Lipolysis. ACS Biomater Sci Eng 2017;3:3646-53. [PMID: 33445399 DOI: 10.1021/acsbiomaterials.7b00549] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 3.5] [Reference Citation Analysis]
99 Yong SB, Song Y, Kim YH. Visceral adipose tissue macrophage-targeted TACE silencing to treat obesity-induced type 2 diabetes. Biomaterials 2017;148:81-9. [PMID: 28985514 DOI: 10.1016/j.biomaterials.2017.09.023] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
100 Cao Y, Matsubara T, Zhao C, Gao W, Peng L, Shan J, Liu Z, Yuan F, Tang L, Li P, Guan Z, Fang Z, Lu X, Huang H, Yang Q. Antisense oligonucleotide and thyroid hormone conjugates for obesity treatment. Sci Rep 2017;7:9307. [PMID: 28839185 DOI: 10.1038/s41598-017-09598-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
101 Kobayashi N, Nakahara M, Oka M, Saeki K. Additional attention to combination antiretroviral therapy-related lipodystrophy. World J Virol 2017; 6(3): 49-52 [PMID: 28868242 DOI: 10.5501/wjv.v6.i3.49] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
102 Li M, Qian M, Xu J. Vascular Endothelial Regulation of Obesity-Associated Insulin Resistance. Front Cardiovasc Med 2017;4:51. [PMID: 28848738 DOI: 10.3389/fcvm.2017.00051] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.2] [Reference Citation Analysis]
103 Ma LL, Shen L, Tong GH, Tang N, Luo Y, Guo LL, Hu CT, Huang YX, Huang G, Jing FY, Liu C, Li ZY, Zhou N, Yan QW, Lei Y, Zhu SJ, Cheng ZQ, Cao GW, Deng YJ, Ding YQ. Prohibitin, relocated to the front ends, can control the migration directionality of colorectal cancer cells. Oncotarget 2017;8:76340-56. [PMID: 29100316 DOI: 10.18632/oncotarget.19394] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
104 S Sibuyi NR, Thovhogi N, Gabuza KB, Meyer MD, Drah M, Onani MO, Skepu A, Madiehe AM, Meyer M. Peptide-functionalized nanoparticles for the selective induction of apoptosis in target cells. Nanomedicine (Lond) 2017;12:1631-45. [PMID: 28635372 DOI: 10.2217/nnm-2017-0085] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
105 Wang F, Han L, Qin RR, Zhang YY, Wang D, Wang ZH, Tang MX, Zhang Y, Zhong M, Zhang W. Overexpressing STAMP2 attenuates adipose tissue angiogenesis and insulin resistance in diabetic ApoE-/- /LDLR-/- mouse via a PPARγ/CD36 pathway. J Cell Mol Med 2017;21:3298-308. [PMID: 28631352 DOI: 10.1111/jcmm.13233] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
106 Jiang C, Cano-Vega MA, Yue F, Kuang L, Narayanan N, Uzunalli G, Merkel MP, Kuang S, Deng M. Dibenzazepine-Loaded Nanoparticles Induce Local Browning of White Adipose Tissue to Counteract Obesity. Mol Ther 2017;25:1718-29. [PMID: 28624262 DOI: 10.1016/j.ymthe.2017.05.020] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 5.0] [Reference Citation Analysis]
107 Yoon I, Park S, Kim R, Ko HL, Nam J. Insulin-sparing and fungible effects of E4orf1 combined with an adipocyte-targeting sequence in mouse models of type 1 and type 2 diabetes. Int J Obes 2017;41:1601-5. [DOI: 10.1038/ijo.2017.142] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
108 Ising C, Bharill P, Brinkkoetter S, Brähler S, Schroeter C, Koehler S, Hagmann H, Merkwirth C, Höhne M, Müller RU, Fabretti F, Schermer B, Bloch W, Kerjaschki D, Kurschat CE, Benzing T, Brinkkoetter PT. Prohibitin-2 Depletion Unravels Extra-Mitochondrial Functions at the Kidney Filtration Barrier. Am J Pathol 2016;186:1128-39. [PMID: 27105734 DOI: 10.1016/j.ajpath.2015.12.018] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
109 Daquinag AC, Dadbin A, Snyder B, Wang X, Sahin AA, Ueno NT, Kolonin MG. Non-glycanated Decorin Is a Drug Target on Human Adipose Stromal Cells. Mol Ther Oncolytics 2017;6:1-9. [PMID: 28607949 DOI: 10.1016/j.omto.2017.05.003] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 3.2] [Reference Citation Analysis]
110 Chandler M, Cunningham S, Lund E, Khanna C, Naramore R, Patel A, Day M. Obesity and Associated Comorbidities in People and Companion Animals: A One Health Perspective. Journal of Comparative Pathology 2017;156:296-309. [DOI: 10.1016/j.jcpa.2017.03.006] [Cited by in Crossref: 90] [Cited by in F6Publishing: 93] [Article Influence: 15.0] [Reference Citation Analysis]
111 Kim DM, Jang H, Shin MG, Kim JH, Shin SM, Min SH, Kim IC. β-catenin induces expression of prohibitin gene in acute leukemic cells. Oncol Rep 2017;37:3201-8. [PMID: 28440457 DOI: 10.3892/or.2017.5599] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
112 Sakurai Y, Kajimoto K, Harashima H. Anti-angiogenic nanotherapy via active targeting systems to tumors and adipose tissue vasculature. Biomater Sci 2015;3:1253-65. [PMID: 26261854 DOI: 10.1039/c5bm00113g] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
113 Shi Y, Conde J, Azevedo HS. Empowering the Potential of Cell-Penetrating Peptides for Targeted Intracellular Delivery via Molecular Self-Assembly. Peptides and Peptide-based Biomaterials and their Biomedical Applications 2017. [DOI: 10.1007/978-3-319-66095-0_12] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
114 Kim MJ, Yu JH, Oh MH, Nam YS, Lee DY. Development of fluorescence-conjugated islet-homing peptide using biopanning for targeted optical imaging of pancreatic islet. Journal of Industrial and Engineering Chemistry 2017;45:404-11. [DOI: 10.1016/j.jiec.2016.10.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
115 Keum DH, Mun JH, Hwang BW, Kim J, Kim H, Jo W, Ha DH, Cho DW, Kim C, Hahn SK. Smart Microbubble Eluting Theranostic Stent for Noninvasive Ultrasound Imaging and Prevention of Restenosis. Small 2017;13. [PMID: 28001324 DOI: 10.1002/smll.201602925] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
116 Tanowitz HB, Scherer PE, Mota MM, Figueiredo LM. Adipose Tissue: A Safe Haven for Parasites? Trends Parasitol 2017;33:276-84. [PMID: 28007406 DOI: 10.1016/j.pt.2016.11.008] [Cited by in Crossref: 53] [Cited by in F6Publishing: 56] [Article Influence: 7.6] [Reference Citation Analysis]
117 Liu Z, Song X, Chen Q, Liu T, Teng J, Zhou K, Luo D. Effect of metformin on global gene expression in liver of KKAy mice. Pharmacological Reports 2016;68:1332-8. [DOI: 10.1016/j.pharep.2016.09.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
118 Hu J, Ye M, Zhou Z. Aptamers: novel diagnostic and therapeutic tools for diabetes mellitus and metabolic diseases. J Mol Med (Berl) 2017;95:249-56. [PMID: 27847965 DOI: 10.1007/s00109-016-1485-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
119 Sato Y, Sakurai Y, Kajimoto K, Nakamura T, Yamada Y, Akita H, Harashima H. Innovative Technologies in Nanomedicines: From Passive Targeting to Active Targeting/From Controlled Pharmacokinetics to Controlled Intracellular Pharmacokinetics. Macromol Biosci 2017;17:1600179. [DOI: 10.1002/mabi.201600179] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
120 Sripathi SR, Sylvester O, He W, Moser T, Um JY, Lamoke F, Ramakrishna W, Bernstein PS, Bartoli M, Jahng WJ. Prohibitin as the Molecular Binding Switch in the Retinal Pigment Epithelium. Protein J 2016;35:1-16. [PMID: 26661103 DOI: 10.1007/s10930-015-9641-y] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
121 Shimizu I, Walsh K. The Whitening of Brown Fat and Its Implications for Weight Management in Obesity. Curr Obes Rep 2015;4:224-9. [PMID: 26627217 DOI: 10.1007/s13679-015-0157-8] [Cited by in Crossref: 66] [Cited by in F6Publishing: 49] [Article Influence: 9.4] [Reference Citation Analysis]
122 Zachwieja NJ, O'Connell GC, Stricker JC, Allen J, Vona-Davis L, Bryner R, Mandler W, Olfert IM. Loss of Adipocyte VEGF Impairs Endurance Exercise Capacity in Mice. Med Sci Sports Exerc 2015;47:2329-39. [PMID: 25785931 DOI: 10.1249/MSS.0000000000000663] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
123 Salameh A, Daquinag AC, Staquicini DI, An Z, Hajjar KA, Pasqualini R, Arap W, Kolonin MG. Prohibitin/annexin 2 interaction regulates fatty acid transport in adipose tissue. JCI Insight 2016;1:e86351. [PMID: 27468426 DOI: 10.1172/jci.insight.86351] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 5.1] [Reference Citation Analysis]
124 Ande SR, Nguyen KH, Nyomba BLG, Mishra S. Prohibitin in Adipose and Immune Functions. Trends Endocrinol Metab 2016;27:531-41. [PMID: 27312736 DOI: 10.1016/j.tem.2016.05.003] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
125 Jung HK, Kim S, Park RW, Park JY, Kim IS, Lee B. Bladder tumor-targeted delivery of pro-apoptotic peptide for cancer therapy. J Control Release 2016;235:259-67. [PMID: 27282414 DOI: 10.1016/j.jconrel.2016.06.008] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 4.9] [Reference Citation Analysis]
126 Yang X, Zhang F, Luo J, Pang J, Yan S, Luo F, Liu J, Wang W, Cui Y, Su X. A new non-muscle-invasive bladder tumor-homing peptide identified by phage display in vivo. Oncol Rep 2016;36:79-89. [PMID: 27221614 DOI: 10.3892/or.2016.4829] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
127 Xue Y, Xu X, Zhang XQ, Farokhzad OC, Langer R. Preventing diet-induced obesity in mice by adipose tissue transformation and angiogenesis using targeted nanoparticles. Proc Natl Acad Sci U S A 2016;113:5552-7. [PMID: 27140638 DOI: 10.1073/pnas.1603840113] [Cited by in Crossref: 95] [Cited by in F6Publishing: 101] [Article Influence: 13.6] [Reference Citation Analysis]
128 Diener C, Garza Ramos Martínez G, Moreno Blas D, Castillo González DA, Corzo G, Castro-Obregon S, Del Rio G. Effective Design of Multifunctional Peptides by Combining Compatible Functions. PLoS Comput Biol 2016;12:e1004786. [PMID: 27096600 DOI: 10.1371/journal.pcbi.1004786] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 3.7] [Reference Citation Analysis]
129 Körbelin J, Sieber T, Michelfelder S, Lunding L, Spies E, Hunger A, Alawi M, Rapti K, Indenbirken D, Müller OJ, Pasqualini R, Arap W, Kleinschmidt JA, Trepel M. Pulmonary Targeting of Adeno-associated Viral Vectors by Next-generation Sequencing-guided Screening of Random Capsid Displayed Peptide Libraries. Mol Ther 2016;24:1050-61. [PMID: 27018516 DOI: 10.1038/mt.2016.62] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 6.4] [Reference Citation Analysis]
130 Wintachai P, Thuaud F, Basmadjian C, Roytrakul S, Ubol S, Désaubry L, Smith DR. Assessment of flavaglines as potential chikungunya virus entry inhibitors. Microbiol Immunol 2015;59:129-41. [PMID: 25643977 DOI: 10.1111/1348-0421.12230] [Cited by in Crossref: 33] [Cited by in F6Publishing: 37] [Article Influence: 4.7] [Reference Citation Analysis]
131 Zhang Y, Tong Y, Gao M, Luo C, Song X, Gao X, Yao W. Expression, purification and characterization of a vascular endothelial growth factor fusion protein. Biotechnol Lett 2016;38:1115-20. [DOI: 10.1007/s10529-016-2081-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
132 Lin P, Caplan AI, Ruoslahti E. Delivery and Targeting of Therapeutic Cells. Stem Cells in Regenerative Medicine 2016. [DOI: 10.1002/9781118846193.ch21] [Reference Citation Analysis]
133 Peng YT, Chen P, Ouyang RY, Song L. Multifaceted role of prohibitin in cell survival and apoptosis. Apoptosis 2015;20:1135-49. [PMID: 26091791 DOI: 10.1007/s10495-015-1143-z] [Cited by in Crossref: 118] [Cited by in F6Publishing: 126] [Article Influence: 16.9] [Reference Citation Analysis]
134 Yao VJ, D'Angelo S, Butler KS, Theron C, Smith TL, Marchiò S, Gelovani JG, Sidman RL, Dobroff AS, Brinker CJ, Bradbury ARM, Arap W, Pasqualini R. Ligand-targeted theranostic nanomedicines against cancer. J Control Release 2016;240:267-86. [PMID: 26772878 DOI: 10.1016/j.jconrel.2016.01.002] [Cited by in Crossref: 123] [Cited by in F6Publishing: 130] [Article Influence: 17.6] [Reference Citation Analysis]
135 Ravussin E, Smith SR. Role of the Adipocyte in Metabolism and Endocrine Function. Endocrinology: Adult and Pediatric. Elsevier; 2016. pp. 627-647.e9. [DOI: 10.1016/b978-0-323-18907-1.00036-6] [Cited by in Crossref: 4] [Article Influence: 0.6] [Reference Citation Analysis]
136 Nicastro J, Wong S, Slavcev RA. Phage-Mediated Immunomodulation. Bacteriophage Applications - Historical Perspective and Future Potential 2016. [DOI: 10.1007/978-3-319-45791-8_7] [Reference Citation Analysis]
137 Wu X, Zhang Q, Xu S, Jin P, Luan P, Li Y, Cao Z, Leng L, Wang Y, Wang S. Differential expression of six chicken genes associated with fatness traits in a divergently selected broiler population. Mol Cell Probes 2016;30:1-5. [PMID: 26746358 DOI: 10.1016/j.mcp.2015.12.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
138 Yamashita H, Kusudo T, Takeuchi T, Qiao S, Tsutsumiuchi K, Wang T, Wang Y. Dietary supplementation with evodiamine prevents obesity and improves insulin resistance in ageing mice. Journal of Functional Foods 2015;19:320-9. [DOI: 10.1016/j.jff.2015.09.032] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
139 Londono-Renteria B, Troupin A, Conway MJ, Vesely D, Ledizet M, Roundy CM, Cloherty E, Jameson S, Vanlandingham D, Higgs S, Fikrig E, Colpitts TM. Dengue Virus Infection of Aedes aegypti Requires a Putative Cysteine Rich Venom Protein. PLoS Pathog 2015;11:e1005202. [PMID: 26491875 DOI: 10.1371/journal.ppat.1005202] [Cited by in Crossref: 42] [Cited by in F6Publishing: 42] [Article Influence: 5.3] [Reference Citation Analysis]
140 Akita H, Fujiwara T, Santiwarangkool S, Hossen N, Kajimoto K, El-Sayed A, Tabata Y, Harashima H. Transcytosis-Targeting Peptide: A Conductor of Liposomal Nanoparticles through the Endothelial Cell Barrier. Small 2016;12:1212-21. [PMID: 26426116 DOI: 10.1002/smll.201500909] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
141 Derosa G, Mugellini A, Pesce RM, D'Angelo A, Maffioli P. Perindopril and barnidipine alone or combined with simvastatin on hepatic steatosis and inflammatory parameters in hypertensive patients. Eur J Pharmacol 2015;766:31-6. [PMID: 26407654 DOI: 10.1016/j.ejphar.2015.09.030] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
142 Liu S, Wang W, Brown LE, Qiu C, Lajkiewicz N, Zhao T, Zhou J, Porco JA Jr, Wang TT. A Novel Class of Small Molecule Compounds that Inhibit Hepatitis C Virus Infection by Targeting the Prohibitin-CRaf Pathway. EBioMedicine 2015;2:1600-6. [PMID: 26870784 DOI: 10.1016/j.ebiom.2015.09.018] [Cited by in Crossref: 34] [Cited by in F6Publishing: 38] [Article Influence: 4.3] [Reference Citation Analysis]
143 Zhang Y, Nowicka A, Solley TN, Wei C, Parikh A, Court L, Burks JK, Andreeff M, Woodward WA, Dadbin A, Kolonin MG, Lu KH, Klopp AH. Stromal Cells Derived from Visceral and Obese Adipose Tissue Promote Growth of Ovarian Cancers. PLoS One 2015;10:e0136361. [PMID: 26317219 DOI: 10.1371/journal.pone.0136361] [Cited by in Crossref: 23] [Cited by in F6Publishing: 29] [Article Influence: 2.9] [Reference Citation Analysis]
144 Daquinag AC, Tseng C, Zhang Y, Amaya-Manzanares F, Florez F, Dadbin A, Zhang T, Kolonin MG. Targeted Proapoptotic Peptides Depleting Adipose Stromal Cells Inhibit Tumor Growth. Mol Ther 2016;24:34-40. [PMID: 26316391 DOI: 10.1038/mt.2015.155] [Cited by in Crossref: 25] [Cited by in F6Publishing: 31] [Article Influence: 3.1] [Reference Citation Analysis]
145 Kreit M, Vertommen D, Gillet L, Michiels T. The Interferon-Inducible Mouse Apolipoprotein L9 and Prohibitins Cooperate to Restrict Theiler's Virus Replication. PLoS One 2015;10:e0133190. [PMID: 26196674 DOI: 10.1371/journal.pone.0133190] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.8] [Reference Citation Analysis]
146 van Duijl-Richter MK, Hoornweg TE, Rodenhuis-Zybert IA, Smit JM. Early Events in Chikungunya Virus Infection-From Virus Cell Binding to Membrane Fusion. Viruses 2015;7:3647-74. [PMID: 26198242 DOI: 10.3390/v7072792] [Cited by in Crossref: 82] [Cited by in F6Publishing: 84] [Article Influence: 10.3] [Reference Citation Analysis]
147 Parray HA, Yun JW. Proteomic Identification of Target Proteins of Thiodigalactoside in White Adipose Tissue from Diet-Induced Obese Rats. Int J Mol Sci 2015;16:14441-63. [PMID: 26121299 DOI: 10.3390/ijms160714441] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
148 Zhu X, Xu Y, Solis LM, Tao W, Wang L, Behrens C, Xu X, Zhao L, Liu D, Wu J, Zhang N, Wistuba II, Farokhzad OC, Zetter BR, Shi J. Long-circulating siRNA nanoparticles for validating Prohibitin1-targeted non-small cell lung cancer treatment. Proc Natl Acad Sci U S A 2015;112:7779-84. [PMID: 26056316 DOI: 10.1073/pnas.1505629112] [Cited by in Crossref: 133] [Cited by in F6Publishing: 143] [Article Influence: 16.6] [Reference Citation Analysis]
149 Choi M, Chaudhari HN, Ji YR, Ryoo ZY, Kim SW, Yun JW. Effect of estrogen on expression of prohibitin in white adipose tissue and liver of diet-induced obese rats. Mol Cell Biochem 2015;407:181-96. [DOI: 10.1007/s11010-015-2468-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
150 Hayashi Y, Hatakeyama H, Kajimoto K, Hyodo M, Akita H, Harashima H. Multifunctional Envelope-Type Nano Device: Evolution from Nonselective to Active Targeting System. Bioconjug Chem 2015;26:1266-76. [PMID: 25938819 DOI: 10.1021/acs.bioconjchem.5b00184] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
151 Trepel M, Körbelin J, Spies E, Heckmann MB, Hunger A, Fehse B, Katus HA, Kleinschmidt JA, Müller OJ, Michelfelder S. Treatment of multifocal breast cancer by systemic delivery of dual-targeted adeno-associated viral vectors. Gene Ther. 2015;22:840-847. [PMID: 26034897 DOI: 10.1038/gt.2015.52] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
152 Myerson JW, Brenner JS, Greineder CF, Muzykantov VR. Systems approaches to design of targeted therapeutic delivery. Wiley Interdiscip Rev Syst Biol Med 2015;7:253-65. [PMID: 25946066 DOI: 10.1002/wsbm.1304] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
153 Omidfar K, Daneshpour M. Advances in phage display technology for drug discovery. Expert Opin Drug Discov 2015;10:651-69. [PMID: 25910798 DOI: 10.1517/17460441.2015.1037738] [Cited by in Crossref: 75] [Cited by in F6Publishing: 75] [Article Influence: 9.4] [Reference Citation Analysis]
154 Pasqualini R, Millikan RE, Christianson DR, Cardó-Vila M, Driessen WH, Giordano RJ, Hajitou A, Hoang AG, Wen S, Barnhart KF, Baze WB, Marcott VD, Hawke DH, Do KA, Navone NM, Efstathiou E, Troncoso P, Lobb RR, Logothetis CJ, Arap W. Targeting the interleukin-11 receptor α in metastatic prostate cancer: A first-in-man study. Cancer 2015;121:2411-21. [PMID: 25832466 DOI: 10.1002/cncr.29344] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 4.6] [Reference Citation Analysis]
155 Karjalainen K, Jaalouk DE, Bueso-Ramos C, Bover L, Sun Y, Kuniyasu A, Driessen WH, Cardó-Vila M, Rietz C, Zurita AJ, O'Brien S, Kantarjian HM, Cortes JE, Calin GA, Koivunen E, Arap W, Pasqualini R. Targeting IL11 Receptor in Leukemia and Lymphoma: A Functional Ligand-Directed Study and Hematopathology Analysis of Patient-Derived Specimens. Clin Cancer Res 2015;21:3041-51. [PMID: 25779950 DOI: 10.1158/1078-0432.CCR-13-3059] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
156 Thovhogi N, Sibuyi N, Meyer M, Onani M, Madiehe A. Targeted delivery using peptide-functionalised gold nanoparticles to white adipose tissues of obese rats. J Nanopart Res 2015;17. [DOI: 10.1007/s11051-015-2904-x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 3.4] [Reference Citation Analysis]
157 Dobroff AS, Rangel R, Guzman-Roja L, Salmeron CC, Gelovani JG, Sidman RL, Bologa CG, Oprea TI, Brinker CJ, Pasqualini R, Arap W. Ligand-directed profiling of organelles with internalizing phage libraries. Curr Protoc Protein Sci 2015;79:30.4.1-30.4.30. [PMID: 25640897 DOI: 10.1002/0471140864.ps3004s79] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
158 Bertolini F, Petit JY, Kolonin MG. Stem cells from adipose tissue and breast cancer: hype, risks and hope. Br J Cancer 2015;112:419-23. [PMID: 25584493 DOI: 10.1038/bjc.2014.657] [Cited by in Crossref: 62] [Cited by in F6Publishing: 72] [Article Influence: 7.8] [Reference Citation Analysis]
159 Sakurai Y, Kajimoto K, Hatakeyama H, Harashima H. Advances in an active and passive targeting to tumor and adipose tissues. Expert Opin Drug Deliv 2015;12:41-52. [PMID: 25376864 DOI: 10.1517/17425247.2015.955847] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 3.9] [Reference Citation Analysis]
160 Lauer RC, Friend SC, Rietz C, Pasqualini R, Arap W. Drug design strategies for the treatment of prostate cancer. Expert Opin Drug Discov 2015;10:81-90. [PMID: 25366417 DOI: 10.1517/17460441.2015.978855] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
161 Daquinag AC, Tseng C, Salameh A, Zhang Y, Amaya-Manzanares F, Dadbin A, Florez F, Xu Y, Tong Q, Kolonin MG. Depletion of white adipocyte progenitors induces beige adipocyte differentiation and suppresses obesity development. Cell Death Differ 2015;22:351-63. [PMID: 25342467 DOI: 10.1038/cdd.2014.148] [Cited by in Crossref: 45] [Cited by in F6Publishing: 48] [Article Influence: 5.0] [Reference Citation Analysis]
162 Lapid K, Lim A, Clegg DJ, Zeve D, Graff JM. Oestrogen signalling in white adipose progenitor cells inhibits differentiation into brown adipose and smooth muscle cells. Nat Commun 2014;5:5196. [PMID: 25330806 DOI: 10.1038/ncomms6196] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 4.1] [Reference Citation Analysis]
163 Won YW, Adhikary PP, Lim KS, Kim HJ, Kim JK, Kim YH. Oligopeptide complex for targeted non-viral gene delivery to adipocytes. Nat Mater 2014;13:1157-64. [PMID: 25282508 DOI: 10.1038/nmat4092] [Cited by in Crossref: 92] [Cited by in F6Publishing: 94] [Article Influence: 10.2] [Reference Citation Analysis]
164 Prashanth A, Jeyakumar SM, Singotamu L, Harishankar N, Giridharan NV, Vajreswari A. Mitochondriogenesis and apoptosis: possible cause of vitamin A-mediated adipose loss in WNIN/Ob-obese rats. Nutr Metab (Lond) 2014;11:45. [PMID: 25302071 DOI: 10.1186/1743-7075-11-45] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
165 Cerk IK, Salzburger B, Boeszoermenyi A, Heier C, Pillip C, Romauch M, Schweiger M, Cornaciu I, Lass A, Zimmermann R, Zechner R, Oberer M. A peptide derived from G0/G1 switch gene 2 acts as noncompetitive inhibitor of adipose triglyceride lipase. J Biol Chem 2014;289:32559-70. [PMID: 25258314 DOI: 10.1074/jbc.M114.602599] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 3.4] [Reference Citation Analysis]
166 Kajimoto K, Sato Y, Nakamura T, Yamada Y, Harashima H. Multifunctional envelope-type nano device for controlled intracellular trafficking and selective targeting in vivo. Journal of Controlled Release 2014;190:593-606. [DOI: 10.1016/j.jconrel.2014.03.058] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 4.4] [Reference Citation Analysis]
167 Vaicik M, Cohen R, Brey E. Vascularization in Engineered Adipose Tissue. Vascularization 2014. [DOI: 10.1201/b16777-22] [Reference Citation Analysis]
168 Laßek M, Weingarten J, Volknandt W. The synaptic proteome. Cell Tissue Res 2015;359:255-65. [PMID: 25038742 DOI: 10.1007/s00441-014-1943-4] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 3.1] [Reference Citation Analysis]
169 Peirce V, Carobbio S, Vidal-Puig A. The different shades of fat. Nature 2014;510:76-83. [PMID: 24899307 DOI: 10.1038/nature13477] [Cited by in Crossref: 322] [Cited by in F6Publishing: 330] [Article Influence: 35.8] [Reference Citation Analysis]
170 Hossen MN, Kajimoto K, Tatsumi R, Hyodo M, Harashima H. Comparative assessments of crucial factors for a functional ligand-targeted nanocarrier. J Drug Target 2014;22:600-9. [PMID: 24806515 DOI: 10.3109/1061186X.2014.915552] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
171 Gupta A, Oppenheim AB, Chaudhary VK. Phage Display: a Molecular Fashion Show. Phages 2014. [DOI: 10.1128/9781555816506.ch21] [Reference Citation Analysis]
172 Laßek M, Weingarten J, Volknandt W. The Proteome of the Murine Presynaptic Active Zone. Proteomes 2014;2:243-57. [PMID: 28250380 DOI: 10.3390/proteomes2020243] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
173 Azhdarinia A, Daquinag AC, Tseng C, Ghosh SC, Ghosh P, Amaya-Manzanares F, Sevick-Muraca E, Kolonin MG. A peptide probe for targeted brown adipose tissue imaging. Nat Commun 2013;4:2472. [PMID: 24045463 DOI: 10.1038/ncomms3472] [Cited by in Crossref: 44] [Cited by in F6Publishing: 46] [Article Influence: 4.9] [Reference Citation Analysis]
174 Shimizu I, Aprahamian T, Kikuchi R, Shimizu A, Papanicolaou KN, MacLauchlan S, Maruyama S, Walsh K. Vascular rarefaction mediates whitening of brown fat in obesity. J Clin Invest 2014;124:2099-112. [PMID: 24713652 DOI: 10.1172/JCI71643] [Cited by in Crossref: 251] [Cited by in F6Publishing: 261] [Article Influence: 27.9] [Reference Citation Analysis]
175 Rosen ED, Spiegelman BM. What we talk about when we talk about fat. Cell. 2014;156:20-44. [PMID: 24439368 DOI: 10.1016/j.cell.2013.12.012] [Cited by in Crossref: 1414] [Cited by in F6Publishing: 1458] [Article Influence: 157.1] [Reference Citation Analysis]
176 Rodriguez Plaza JG, Morales-Nava R, Diener C, Schreiber G, Gonzalez ZD, Lara Ortiz MT, Ortega Blake I, Pantoja O, Volkmer R, Klipp E, Herrmann A, Del Rio G. Cell penetrating peptides and cationic antibacterial peptides: two sides of the same coin. J Biol Chem 2014;289:14448-57. [PMID: 24706763 DOI: 10.1074/jbc.M113.515023] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 4.0] [Reference Citation Analysis]
177 D'Onofrio N, Caraglia M, Grimaldi A, Marfella R, Servillo L, Paolisso G, Balestrieri ML. Vascular-homing peptides for targeted drug delivery and molecular imaging: meeting the clinical challenges. Biochim Biophys Acta 2014;1846:1-12. [PMID: 24704283 DOI: 10.1016/j.bbcan.2014.03.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
178 Kolonin MG. How brown is brown fat that we can see? Adipocyte 2014;3:155-9. [PMID: 24719791 DOI: 10.4161/adip.27747] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
179 Zhang S, Yu M, Wei Y. Do anti-angiogenic cancer therapies increase risk of significant weight loss? Expert Opin Drug Saf 2014;13:473-82. [PMID: 24588304 DOI: 10.1517/14740338.2014.894506] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
180 Luan Z, He Y, Alattar M, Chen Z, He F. Targeting the prohibitin scaffold-CRAF kinase interaction in RAS-ERK-driven pancreatic ductal adenocarcinoma. Mol Cancer 2014;13:38. [PMID: 24568222 DOI: 10.1186/1476-4598-13-38] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 3.9] [Reference Citation Analysis]
181 Wang T, Kusudo T, Takeuchi T, Yamashita Y, Kontani Y, Okamatsu Y, Saito M, Mori N, Yamashita H. Evodiamine inhibits insulin-stimulated mTOR-S6K activation and IRS1 serine phosphorylation in adipocytes and improves glucose tolerance in obese/diabetic mice. PLoS One 2013;8:e83264. [PMID: 24391749 DOI: 10.1371/journal.pone.0083264] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 2.8] [Reference Citation Analysis]
182 Song W, Tian L, Li SS, Shen DY, Chen QX. The aberrant expression and localization of prohibitin during apoptosis of human cholangiocarcinoma Mz-ChA-1 cells. FEBS Lett 2014;588:422-8. [PMID: 24380853 DOI: 10.1016/j.febslet.2013.12.021] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
183 Gray BP, Brown KC. Combinatorial peptide libraries: mining for cell-binding peptides. Chem Rev 2014;114:1020-81. [PMID: 24299061 DOI: 10.1021/cr400166n] [Cited by in Crossref: 155] [Cited by in F6Publishing: 164] [Article Influence: 15.5] [Reference Citation Analysis]
184 Kawamura E, Yamada Y, Harashima H. Mitochondrial targeting functional peptides as potential devices for the mitochondrial delivery of a DF-MITO-Porter. Mitochondrion 2013;13:610-4. [DOI: 10.1016/j.mito.2013.08.010] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 3.2] [Reference Citation Analysis]
185 Rashad AA, Mahalingam S, Keller PA. Chikungunya virus: emerging targets and new opportunities for medicinal chemistry. J Med Chem 2014;57:1147-66. [PMID: 24079775 DOI: 10.1021/jm400460d] [Cited by in Crossref: 64] [Cited by in F6Publishing: 65] [Article Influence: 6.4] [Reference Citation Analysis]
186 Barbu EM, Shirazi F, McGrath DM, Albert N, Sidman RL, Pasqualini R, Arap W, Kontoyiannis DP. An antimicrobial peptidomimetic induces Mucorales cell death through mitochondria-mediated apoptosis. PLoS One 2013;8:e76981. [PMID: 24098573 DOI: 10.1371/journal.pone.0076981] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
187 Catalán V, Gómez-Ambrosi J, Rodríguez A, Frühbeck G. Adipose tissue immunity and cancer. Front Physiol 2013;4:275. [PMID: 24106481 DOI: 10.3389/fphys.2013.00275] [Cited by in Crossref: 86] [Cited by in F6Publishing: 94] [Article Influence: 8.6] [Reference Citation Analysis]
188 Rangel R, Dobroff AS, Guzman-Rojas L, Salmeron CC, Gelovani JG, Sidman RL, Pasqualini R, Arap W. Targeting mammalian organelles with internalizing phage (iPhage) libraries. Nat Protoc 2013;8:1916-39. [PMID: 24030441 DOI: 10.1038/nprot.2013.119] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
189 Kim DK, Kim HS, Kim AR, Jang GH, Kim HW, Park YH, Kim B, Park YM, Beaven MA, Kim YM, Choi WS. The scaffold protein prohibitin is required for antigen-stimulated signaling in mast cells. Sci Signal 2013;6:ra80. [PMID: 24023254 DOI: 10.1126/scisignal.2004098] [Cited by in Crossref: 23] [Cited by in F6Publishing: 29] [Article Influence: 2.3] [Reference Citation Analysis]
190 Thuaud F, Ribeiro N, Nebigil CG, Désaubry L. Prohibitin ligands in cell death and survival: mode of action and therapeutic potential. Chem Biol 2013;20:316-31. [PMID: 23521790 DOI: 10.1016/j.chembiol.2013.02.006] [Cited by in Crossref: 135] [Cited by in F6Publishing: 149] [Article Influence: 13.5] [Reference Citation Analysis]
191 Hossen N, Kajimoto K, Akita H, Hyodo M, Harashima H. A comparative study between nanoparticle-targeted therapeutics and bioconjugates as obesity medication. J Control Release 2013;171:104-12. [PMID: 23871959 DOI: 10.1016/j.jconrel.2013.07.013] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 3.3] [Reference Citation Analysis]
192 Supale S, Thorel F, Merkwirth C, Gjinovci A, Herrera PL, Scorrano L, Meda P, Langer T, Maechler P. Loss of prohibitin induces mitochondrial damages altering β-cell function and survival and is responsible for gradual diabetes development. Diabetes 2013;62:3488-99. [PMID: 23863811 DOI: 10.2337/db13-0152] [Cited by in Crossref: 62] [Cited by in F6Publishing: 65] [Article Influence: 6.2] [Reference Citation Analysis]
193 Van de Voorde J, Pauwels B, Boydens C, Decaluwé K. Adipocytokines in relation to cardiovascular disease. Metabolism 2013;62:1513-21. [PMID: 23866981 DOI: 10.1016/j.metabol.2013.06.004] [Cited by in Crossref: 146] [Cited by in F6Publishing: 132] [Article Influence: 14.6] [Reference Citation Analysis]
194 Yilmaz M, Hotamisligil GS. Damned if you do, damned if you don't: the conundrum of adipose tissue vascularization. Cell Metab 2013;17:7-9. [PMID: 23312279 DOI: 10.1016/j.cmet.2012.12.014] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
195 Sirin O, Kolonin MG. Treatment of obesity as a potential complementary approach to cancer therapy. Drug Discovery Today 2013;18:567-73. [DOI: 10.1016/j.drudis.2012.05.008] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 2.9] [Reference Citation Analysis]
196 Ramos-Nino ME. The role of chronic inflammation in obesity-associated cancers. ISRN Oncol. 2013;2013:697521. [PMID: 23819063 DOI: 10.1155/2013/697521] [Cited by in Crossref: 34] [Cited by in F6Publishing: 63] [Article Influence: 3.4] [Reference Citation Analysis]
197 Kajimoto K, Hossen N, Harashima H. Antiangiogenic nanotherapy for the control of obesity. Nanomedicine 2013;8:671-3. [DOI: 10.2217/nnm.13.27] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
198 Bábíčková J, Tóthová Ľ, Boor P, Celec P. In vivo phage display--a discovery tool in molecular biomedicine. Biotechnol Adv 2013;31:1247-59. [PMID: 23623852 DOI: 10.1016/j.biotechadv.2013.04.004] [Cited by in Crossref: 49] [Cited by in F6Publishing: 49] [Article Influence: 4.9] [Reference Citation Analysis]
199 Herold C, Rennekampff HO, Engeli S. Apoptotic pathways in adipose tissue. Apoptosis 2013;18:911-6. [DOI: 10.1007/s10495-013-0848-0] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 3.2] [Reference Citation Analysis]
200 Staquicini FI, Pasqualini R, Arap W. Ligand-directed profiling: applications to target drug discovery in cancer. Expert Opin Drug Discov 2009;4:51-9. [PMID: 23480336 DOI: 10.1517/17460440802628152] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
201 Miao YR, Eckhardt BL, Cao Y, Pasqualini R, Argani P, Arap W, Ramsay RG, Anderson RL. Inhibition of established micrometastases by targeted drug delivery via cell surface-associated GRP78. Clin Cancer Res. 2013;19:2107-2116. [PMID: 23470966 DOI: 10.1158/1078-0432.ccr-12-2991] [Cited by in Crossref: 57] [Cited by in F6Publishing: 62] [Article Influence: 5.7] [Reference Citation Analysis]
202 Wintachai P, Wikan N, Kuadkitkan A, Jaimipuk T, Ubol S, Pulmanausahakul R, Auewarakul P, Kasinrerk W, Weng WY, Panyasrivanit M, Paemanee A, Kittisenachai S, Roytrakul S, Smith DR. Identification of prohibitin as a Chikungunya virus receptor protein. J Med Virol 2012;84:1757-70. [PMID: 22997079 DOI: 10.1002/jmv.23403] [Cited by in Crossref: 117] [Cited by in F6Publishing: 120] [Article Influence: 11.7] [Reference Citation Analysis]
203 McGrath DM, Barbu EM, Driessen WH, Lasco TM, Tarrand JJ, Okhuysen PC, Kontoyiannis DP, Sidman RL, Pasqualini R, Arap W. Mechanism of action and initial evaluation of a membrane active all-D-enantiomer antimicrobial peptidomimetic. Proc Natl Acad Sci U S A 2013;110:3477-82. [PMID: 23345420 DOI: 10.1073/pnas.1221924110] [Cited by in Crossref: 42] [Cited by in F6Publishing: 45] [Article Influence: 4.2] [Reference Citation Analysis]
204 Feng B, Zhang T, Xu H. Human adipose dynamics and metabolic health. Ann N Y Acad Sci. 2013;1281:160-177. [PMID: 23317303 DOI: 10.1111/nyas.12009] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 4.2] [Reference Citation Analysis]
205 Hossen MN, Kajimoto K, Akita H, Hyodo M, Ishitsuka T, Harashima H. Therapeutic assessment of cytochrome C for the prevention of obesity through endothelial cell-targeted nanoparticulate system. Mol Ther 2013;21:533-41. [PMID: 23295953 DOI: 10.1038/mt.2012.256] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 2.6] [Reference Citation Analysis]
206 Bellows C, Tilg H. Increased Adiposity and Colorectal Cancer. Adipose Tissue and Cancer 2013. [DOI: 10.1007/978-1-4614-7660-3_2] [Reference Citation Analysis]
207 Tseng C, Kolonin MG. Adipose Tissue-Derived Progenitor Cells and Cancer. Angiogenesis in Adipose Tissue 2013. [DOI: 10.1007/978-1-4614-8069-3_15] [Reference Citation Analysis]
208 Salameh A, Kolonin MG. Vascular Targeting of Adipose Tissue. Obesity, Inflammation and Cancer 2013. [DOI: 10.1007/978-1-4614-6819-6_15] [Reference Citation Analysis]
209 Zhang T, Kolonin MG. Role of Adipose Cells in Tumor Microenvironment. The Mechanobiology of Obesity and Related Diseases 2013. [DOI: 10.1007/8415_2013_171] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
210 Matsuo K, Gray MJ, Yang DY, Srivastava SA, Tripathi PB, Sonoda LA, Yoo EJ, Dubeau L, Lee AS, Lin YG. The endoplasmic reticulum stress marker, glucose-regulated protein-78 (GRP78) in visceral adipocytes predicts endometrial cancer progression and patient survival. Gynecol Oncol 2013;128:552-9. [PMID: 23200913 DOI: 10.1016/j.ygyno.2012.11.024] [Cited by in Crossref: 45] [Cited by in F6Publishing: 46] [Article Influence: 4.1] [Reference Citation Analysis]
211 Jung E, Lee NK, Kang S, Choi S, Kim D, Park K, Choi K, Choi Y, Jung DH. Identification of tissue-specific targeting peptide. J Comput Aided Mol Des 2012;26:1267-75. [DOI: 10.1007/s10822-012-9614-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
212 Henry M, Debarbieux L. Tools from viruses: bacteriophage successes and beyond. Virology 2012;434:151-61. [PMID: 23063405 DOI: 10.1016/j.virol.2012.09.017] [Cited by in Crossref: 53] [Cited by in F6Publishing: 42] [Article Influence: 4.8] [Reference Citation Analysis]
213 Hossen MN, Kajimoto K, Akita H, Hyodo M, Harashima H. Vascular-targeted nanotherapy for obesity: Unexpected passive targeting mechanism to obese fat for the enhancement of active drug delivery. Journal of Controlled Release 2012;163:101-10. [DOI: 10.1016/j.jconrel.2012.09.002] [Cited by in Crossref: 47] [Cited by in F6Publishing: 42] [Article Influence: 4.3] [Reference Citation Analysis]
214 Ye J, Gimble JM. Regulation of stem cell differentiation in adipose tissue by chronic inflammation. Clin Exp Pharmacol Physiol 2011;38:872-8. [PMID: 21883381 DOI: 10.1111/j.1440-1681.2011.05596.x] [Cited by in Crossref: 47] [Cited by in F6Publishing: 48] [Article Influence: 4.3] [Reference Citation Analysis]
215 Li ZJ, Cho CH. Peptides as targeting probes against tumor vasculature for diagnosis and drug delivery. J Transl Med 2012;10 Suppl 1:S1. [PMID: 23046982 DOI: 10.1186/1479-5876-10-S1-S1] [Cited by in Crossref: 66] [Cited by in F6Publishing: 73] [Article Influence: 6.0] [Reference Citation Analysis]
216 Kim DH, Gutierrez-Aguilar R, Kim HJ, Woods SC, Seeley RJ. Increased adipose tissue hypoxia and capacity for angiogenesis and inflammation in young diet-sensitive C57 mice compared with diet-resistant FVB mice. Int J Obes (Lond) 2013;37:853-60. [PMID: 22964790 DOI: 10.1038/ijo.2012.141] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 2.5] [Reference Citation Analysis]
217 Zhang W, Ambati S, Della-fera MA, Choi Y, Baile CA, Andacht TM. Leptin Modulated Changes in Adipose Tissue Protein Expression in ob/ob Mice. Obesity 2011;19:255-61. [DOI: 10.1038/oby.2010.166] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
218 Kral JG. Preventing and Treating Obesity in Girls and Young Women to Curb the Epidemic. Obesity Research 2004;12:1539-46. [DOI: 10.1038/oby.2004.193] [Cited by in Crossref: 49] [Cited by in F6Publishing: 54] [Article Influence: 4.5] [Reference Citation Analysis]
219 Bazan J, Całkosiński I, Gamian A. Phage display--a powerful technique for immunotherapy: 1. Introduction and potential of therapeutic applications. Hum Vaccin Immunother 2012;8:1817-28. [PMID: 22906939 DOI: 10.4161/hv.21703] [Cited by in Crossref: 132] [Cited by in F6Publishing: 132] [Article Influence: 12.0] [Reference Citation Analysis]
220 Dietrich MO, Horvath TL. Limitations in anti-obesity drug development: the critical role of hunger-promoting neurons. Nat Rev Drug Discov 2012;11:675-91. [DOI: 10.1038/nrd3739] [Cited by in Crossref: 144] [Cited by in F6Publishing: 148] [Article Influence: 13.1] [Reference Citation Analysis]
221 Lee NK, Kim HS, Kim KH, Kim EB, Cho CS, Kang SK, Choi YJ. Identification of a novel peptide ligand targeting visceral adipose tissue via transdermal route by in vivo phage display. J Drug Target 2011;19:805-13. [PMID: 21999821 DOI: 10.3109/1061186X.2011.572974] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
222 Ruoslahti E. Peptides as targeting elements and tissue penetration devices for nanoparticles. Adv Mater 2012;24:3747-56. [PMID: 22550056 DOI: 10.1002/adma.201200454] [Cited by in Crossref: 310] [Cited by in F6Publishing: 321] [Article Influence: 28.2] [Reference Citation Analysis]
223 Rodríguez Plaza JG, Villalón Rojas A, Herrera S, Garza-Ramos G, Torres Larios A, Amero C, Zarraga Granados G, Gutiérrez Aguilar M, Lara Ortiz MT, Polanco Gonzalez C, Uribe Carvajal S, Coria R, Peña Díaz A, Bredesen DE, Castro-Obregon S, del Rio G. Moonlighting peptides with emerging function. PLoS One 2012;7:e40125. [PMID: 22808104 DOI: 10.1371/journal.pone.0040125] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
224 Kuadkitkan A, Smith DR, Berry C. Investigation of the Cry4B-prohibitin interaction in Aedes aegypti cells. Curr Microbiol 2012;65:446-54. [PMID: 22767320 DOI: 10.1007/s00284-012-0178-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
225 Kim DH, Sartor MA, Bain JR, Sandoval D, Stevens RD, Medvedovic M, Newgard CB, Woods SC, Seeley RJ. Rapid and weight-independent improvement of glucose tolerance induced by a peptide designed to elicit apoptosis in adipose tissue endothelium. Diabetes 2012;61:2299-310. [PMID: 22733798 DOI: 10.2337/db11-1579] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
226 Gómez-Gaviro MV, Lovell-Badge R, Fernández-Avilés F, Lara-Pezzi E. The vascular stem cell niche. J Cardiovasc Transl Res 2012;5:618-30. [PMID: 22644724 DOI: 10.1007/s12265-012-9371-x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 42] [Article Influence: 4.5] [Reference Citation Analysis]
227 Liu J, Liu H, Sefah K, Liu B, Pu Y, Van Simaeys D, Tan W. Selection of aptamers specific for adipose tissue. PLoS One 2012;7:e37789. [PMID: 22662223 DOI: 10.1371/journal.pone.0037789] [Cited by in Crossref: 27] [Cited by in F6Publishing: 32] [Article Influence: 2.5] [Reference Citation Analysis]
228 Gollasch M. Vasodilator signals from perivascular adipose tissue. Br J Pharmacol 2012;165:633-42. [PMID: 21486288 DOI: 10.1111/j.1476-5381.2011.01430.x] [Cited by in Crossref: 110] [Cited by in F6Publishing: 116] [Article Influence: 10.0] [Reference Citation Analysis]
229 Barnhart KF, Christianson DR, Hanley PW, Driessen WH, Bernacky BJ, Baze WB, Wen S, Tian M, Ma J, Kolonin MG, Saha PK, Do KA, Hulvat JF, Gelovani JG, Chan L, Arap W, Pasqualini R. A peptidomimetic targeting white fat causes weight loss and improved insulin resistance in obese monkeys. Sci Transl Med 2011;3:108ra112. [PMID: 22072637 DOI: 10.1126/scitranslmed.3002621] [Cited by in Crossref: 73] [Cited by in F6Publishing: 76] [Article Influence: 6.6] [Reference Citation Analysis]
230 Barnhart KF, Christianson DR, Kolonin MG, Hulvat JF, Chan L, Arap W, Pasqualini R. Response to Comment on “A Peptidomimetic Targeting White Fat Causes Weight Loss and Improved Insulin Resistance in Obese Monkeys”. Sci Transl Med 2012;4. [DOI: 10.1126/scitranslmed.3004103] [Reference Citation Analysis]
231 Rangel R, Guzman-Rojas L, le Roux LG, Staquicini FI, Hosoya H, Barbu EM, Ozawa MG, Nie J, Dunner K Jr, Langley RR, Sage EH, Koivunen E, Gelovani JG, Lobb RR, Sidman RL, Pasqualini R, Arap W. Combinatorial targeting and discovery of ligand-receptors in organelles of mammalian cells. Nat Commun 2012;3:788. [PMID: 22510693 DOI: 10.1038/ncomms1773] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 3.5] [Reference Citation Analysis]
232 Krakoff J. The platform for adipose tissue expansion during positive energy balance. J Clin Endocrinol Metab 2012;97:377-9. [PMID: 22312090 DOI: 10.1210/jc.2011-3320] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
233 Yurugi H, Tanida S, Ishida A, Akita K, Toda M, Inoue M, Nakada H. Expression of prohibitins on the surface of activated T cells. Biochemical and Biophysical Research Communications 2012;420:275-80. [DOI: 10.1016/j.bbrc.2012.02.149] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 2.2] [Reference Citation Analysis]
234 Chou YC, Su HM, Lai TW, Chyuan JH, Chao PM. cis-9, trans-11, trans-13-Conjugated linolenic acid induces apoptosis and sustained ERK phosphorylation in 3T3-L1 preadipocytes. Nutrition 2012;28:803-11. [PMID: 22465903 DOI: 10.1016/j.nut.2011.11.019] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
235 Sun K, Wernstedt Asterholm I, Kusminski CM, Bueno AC, Wang ZV, Pollard JW, Brekken RA, Scherer PE. Dichotomous effects of VEGF-A on adipose tissue dysfunction. Proc Natl Acad Sci U S A 2012;109:5874-9. [PMID: 22451920 DOI: 10.1073/pnas.1200447109] [Cited by in Crossref: 277] [Cited by in F6Publishing: 291] [Article Influence: 25.2] [Reference Citation Analysis]
236 Nagaoka S. Peptide–Lipid Interactions and Functionalities. Food Proteins and Peptides 2012. [DOI: 10.1201/b11768-11] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
237 Lv Z, Zhang X, Liu L, Chen J, Nie Z, Sheng Q, Zhang W, Jiang C, Yu W, Wang D, Wu X, Zhang S, Li J, Zhang Y. Characterization of a gene encoding prohibitin in silkworm, Bombyx mori. Gene 2012;502:118-24. [PMID: 22450364 DOI: 10.1016/j.gene.2012.03.035] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
238 Chiu CF, Ho MY, Peng JM, Hung SW, Lee WH, Liang CM, Liang SM. Raf activation by Ras and promotion of cellular metastasis require phosphorylation of prohibitin in the raft domain of the plasma membrane. Oncogene 2013;32:777-87. [PMID: 22410782 DOI: 10.1038/onc.2012.86] [Cited by in Crossref: 57] [Cited by in F6Publishing: 59] [Article Influence: 5.2] [Reference Citation Analysis]
239 Chiu CF, Peng JM, Hung SW, Liang CM, Liang SM. Recombinant viral capsid protein VP1 suppresses migration and invasion of human cervical cancer by modulating phosphorylated prohibitin in lipid rafts. Cancer Lett 2012;320:205-14. [PMID: 22388104 DOI: 10.1016/j.canlet.2012.02.027] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
240 Zhang Y, Wang Y, Xiang Y, Lee W, Zhang Y. Prohibitins are involved in protease-activated receptor 1-mediated platelet aggregation: PHBs in platelet PAR1 activation. Journal of Thrombosis and Haemostasis 2012;10:411-8. [DOI: 10.1111/j.1538-7836.2011.04607.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 1.9] [Reference Citation Analysis]
241 Bondia-Pons I, Ryan L, Martinez JA. Oxidative stress and inflammation interactions in human obesity. J Physiol Biochem 2012;68:701-11. [PMID: 22351038 DOI: 10.1007/s13105-012-0154-2] [Cited by in Crossref: 243] [Cited by in F6Publishing: 255] [Article Influence: 22.1] [Reference Citation Analysis]
242 Greig JA, Shirley R, Graham D, Denby L, Dominiczak AF, Work LM, Baker AH. Vascular-targeting antioxidant therapy in a model of hypertension and stroke. J Cardiovasc Pharmacol 2010;56:642-50. [PMID: 20838228 DOI: 10.1097/FJC.0b013e3181f8f19f] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
243 Matsuyama A, Yashiroda Y, Yoshida M. Chemical Proteomics: A Global Study of Protein–Small Molecule Interactions. Chemical Genomics 2012. [DOI: 10.1017/cbo9781139021500.005] [Reference Citation Analysis]
244 Fogari R, Maffioli P, Mugellini A, Zoppi A, Lazzari P, Derosa G. Effects of losartan and amlodipine alone or combined with simvastatin in hypertensive patients with nonalcoholic hepatic steatosis. Eur J Gastroenterol Hepatol 2012;24:164-71. [PMID: 22081005 DOI: 10.1097/MEG.0b013e32834ba188] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 2.7] [Reference Citation Analysis]
245 Kolonin MG. Progenitor cell mobilization from extramedullary organs. Methods Mol Biol 2012;904:243-52. [PMID: 22890937 DOI: 10.1007/978-1-61779-943-3_20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 0.1] [Reference Citation Analysis]
246 Seeley R. Treating Obesity Like a Tumor. Cell Metabolism 2012;15:1-2. [DOI: 10.1016/j.cmet.2011.12.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
247 Tawaramoto K, Kotani K, Hashiramoto M, Kanda Y, Nagare T, Sakaue H, Ogawa W, Emoto N, Yanagisawa M, Noda T, Kasuga M, Kaku K. Ablation of 3-phosphoinositide-dependent protein kinase 1 (PDK1) in vascular endothelial cells enhances insulin sensitivity by reducing visceral fat and suppressing angiogenesis. Mol Endocrinol 2012;26:95-109. [PMID: 22108800 DOI: 10.1210/me.2010-0412] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
248 Staquicini FI, Cardó-Vila M, Kolonin MG, Trepel M, Edwards JK, Nunes DN, Sergeeva A, Efstathiou E, Sun J, Almeida NF, Tu SM, Botz GH, Wallace MJ, O'Connell DJ, Krajewski S, Gershenwald JE, Molldrem JJ, Flamm AL, Koivunen E, Pentz RD, Dias-Neto E, Setubal JC, Cahill DJ, Troncoso P, Do KA, Logothetis CJ, Sidman RL, Pasqualini R, Arap W. Vascular ligand-receptor mapping by direct combinatorial selection in cancer patients. Proc Natl Acad Sci U S A 2011;108:18637-42. [PMID: 22049339 DOI: 10.1073/pnas.1114503108] [Cited by in Crossref: 61] [Cited by in F6Publishing: 63] [Article Influence: 5.1] [Reference Citation Analysis]
249 Sripathi SR, He W, Atkinson CL, Smith JJ, Liu Z, Elledge BM, Jahng WJ. Mitochondrial-nuclear communication by prohibitin shuttling under oxidative stress. Biochemistry 2011;50:8342-51. [PMID: 21879722 DOI: 10.1021/bi2008933] [Cited by in Crossref: 50] [Cited by in F6Publishing: 54] [Article Influence: 4.2] [Reference Citation Analysis]
250 Chen J, Wang H, Xu X, Chen W, Zhang X. : . Acta Polymerica Sinica 2011;011:799-811. [DOI: 10.3724/sp.j.1105.2011.11100] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
251 Polanco González C, Nuño Maganda MA, Arias-Estrada M, del Rio G. An FPGA implementation to detect selective cationic antibacterial peptides. PLoS One 2011;6:e21399. [PMID: 21738652 DOI: 10.1371/journal.pone.0021399] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
252 Gimble JM, Bunnell BA, Floyd ZE. Prospecting for adipose progenitor cell biomarkers: biopanning for gold with in vivo phage display. Cell Stem Cell 2011;9:1-2. [PMID: 21683669 DOI: 10.1016/j.stem.2011.06.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
253 Daquinag AC, Zhang Y, Amaya-Manzanares F, Simmons PJ, Kolonin MG. An isoform of decorin is a resistin receptor on the surface of adipose progenitor cells. Cell Stem Cell. 2011;9:74-86. [PMID: 21683670 DOI: 10.1016/j.stem.2011.05.017] [Cited by in Crossref: 149] [Cited by in F6Publishing: 154] [Article Influence: 12.4] [Reference Citation Analysis]
254 Belo VA, Souza-Costa DC, Luizon MR, Izidoro-Toledo TC, Lanna CM, Pinheiro LC, Tanus-Santos JE. Vascular endothelial growth factor haplotypes associated with childhood obesity. DNA Cell Biol 2011;30:709-14. [PMID: 21612402 DOI: 10.1089/dna.2011.1260] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
255 Ishitsuka T, Akita H, Harashima H. Functional improvement of an IRQ-PEG-MEND for delivering genes to the lung. J Control Release 2011;154:77-83. [PMID: 21619903 DOI: 10.1016/j.jconrel.2011.05.012] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
256 Daquinag AC, Zhang Y, Kolonin MG. Vascular targeting of adipose tissue as an anti-obesity approach. Trends in Pharmacological Sciences 2011;32:300-7. [DOI: 10.1016/j.tips.2011.01.004] [Cited by in Crossref: 57] [Cited by in F6Publishing: 50] [Article Influence: 4.8] [Reference Citation Analysis]
257 Petrenko VA, Jayanna PK. Phage-mediated Drug Delivery. Phage Nanobiotechnology 2011. [DOI: 10.1039/bk9780854041848-00055] [Reference Citation Analysis]
258 Lafontan M. Rein, tissu adipeux, adipocytes – quelles nouveautés ? Néphrologie & Thérapeutique 2011;7:69-79. [DOI: 10.1016/j.nephro.2010.11.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
259 Jung E, Choi SH, Lee NK, Kang SK, Choi YJ, Shin JM, Choi K, Jung DH. Machine learning study for the prediction of transdermal peptide. J Comput Aided Mol Des 2011;25:339-47. [PMID: 21448715 DOI: 10.1007/s10822-011-9424-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
260 Keum JW, Hathorne AP, Bermudez H. Controlling forces and pathways in self-assembly using viruses and DNA. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2011;3:282-97. [PMID: 21384560 DOI: 10.1002/wnan.129] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
261 Kanki S, Jaalouk DE, Lee S, Yu AY, Gannon J, Lee RT. Identification of targeting peptides for ischemic myocardium by in vivo phage display. J Mol Cell Cardiol 2011;50:841-8. [PMID: 21316369 DOI: 10.1016/j.yjmcc.2011.02.003] [Cited by in Crossref: 73] [Cited by in F6Publishing: 65] [Article Influence: 6.1] [Reference Citation Analysis]
262 Chopra AR, Kommagani R, Saha P, Louet JF, Salazar C, Song J, Jeong J, Finegold M, Viollet B, DeMayo F, Chan L, Moore DD, O'Malley BW. Cellular energy depletion resets whole-body energy by promoting coactivator-mediated dietary fuel absorption. Cell Metab 2011;13:35-43. [PMID: 21195347 DOI: 10.1016/j.cmet.2010.12.001] [Cited by in Crossref: 68] [Cited by in F6Publishing: 69] [Article Influence: 5.7] [Reference Citation Analysis]
263 Theiss AL, Sitaraman SV. The role and therapeutic potential of prohibitin in disease. Biochim Biophys Acta. 2011;1813:1137-1143. [PMID: 21296110 DOI: 10.1016/j.bbamcr.2011.01.033] [Cited by in Crossref: 108] [Cited by in F6Publishing: 114] [Article Influence: 9.0] [Reference Citation Analysis]
264 Gaich G, Moller DE. OBESITY: NEW MECHANISMS AND TRANSLATIONAL PARADIGMS. Translational Medicine and Drug Discovery 2011. [DOI: 10.1017/cbo9780511976087.006] [Reference Citation Analysis]
265 Gonzalez AM, Leadbeater WE, Burg M, Sims K, Terasaki T, Johanson CE, Stopa EG, Eliceiri BP, Baird A. Targeting choroid plexus epithelia and ventricular ependyma for drug delivery to the central nervous system. BMC Neurosci 2011;12:4. [PMID: 21214926 DOI: 10.1186/1471-2202-12-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
266 He B, Kim TH, Kommagani R, Feng Q, Lanz RB, Jeong JW, DeMayo FJ, Katzenellenbogen BS, Lydon JP, O'Malley BW. Estrogen-regulated prohibitin is required for mouse uterine development and adult function. Endocrinology 2011;152:1047-56. [PMID: 21209023 DOI: 10.1210/en.2010-0732] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 2.1] [Reference Citation Analysis]
267 Sethi JK, Vidal-puig AJ. Adipose Tissue Development, Structure and Function. Metabolic Basis of Obesity 2011. [DOI: 10.1007/978-1-4419-1607-5_3] [Reference Citation Analysis]
268 Sengenès C, Bourlier V, Galitzky J, Zakaroff-girard A, Lafontan M, Bouloumié A. Cellular Remodeling during the Growth of the Adipose Tissue. Global Perspectives on Childhood Obesity 2011. [DOI: 10.1016/b978-0-12-374995-6.10017-9] [Reference Citation Analysis]
269 Kim H, Choi S, Chun B, Kim D. The Role of Adipose Tissue Vasculature in Energy Balance. J Korean Soc Pediatr Endocrinol 2011;16:139. [DOI: 10.6065/jkspe.2011.16.3.139] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
270 Ferrati S, Streiff AK, Srinivasan S, Alexander JF, Bhargava N, Peters AM, Song NE, Tasciotti E, Godin B, Ferrari M, Serda RE. Mass Transport via Cellular Barriers and Endocytosis. Intracellular Delivery 2011. [DOI: 10.1007/978-94-007-1248-5_1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
271 Witkamp RF. Current and future drug targets in weight management. Pharm Res 2011;28:1792-818. [PMID: 21181547 DOI: 10.1007/s11095-010-0341-1] [Cited by in Crossref: 51] [Cited by in F6Publishing: 53] [Article Influence: 3.9] [Reference Citation Analysis]
272 Li Q, Liang Y, Shi S, Liu Q, Xu D, Jing G, Wang S, Kong H. Localization of Prohibitin in the Nuclear Matrix and Alteration of Its Expression During Differentiation of Human Neuroblastoma SK-N-SH Cells Induced by Retinoic Acid. Cell Mol Neurobiol 2011;31:203-11. [DOI: 10.1007/s10571-010-9608-7] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
273 Wu LE, Hocking SL, James DE. Macrophage infiltration and cytokine release in adipose tissue: angiogenesis or inflammation? Diabetol Int 2010;1:26-34. [DOI: 10.1007/s13340-010-0003-x] [Reference Citation Analysis]
274 Qi J, He P, Chen W, Wang H, Wang X, Zhang M. Comparative proteome study of apoptosis induced by As4S4 in retinoid acid resistant human acute promyelocytic leukemia NB4-R1 cells. Leukemia Research 2010;34:1506-16. [DOI: 10.1016/j.leukres.2010.03.038] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 1.2] [Reference Citation Analysis]
275 Di C, Xu W, Su Z, Yuan JS. Comparative genome analysis of PHB gene family reveals deep evolutionary origins and diverse gene function. BMC Bioinformatics 2010;11 Suppl 6:S22. [PMID: 20946606 DOI: 10.1186/1471-2105-11-S6-S22] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
276 Souza GR, Staquicini FI, Christianson DR, Ozawa MG, Miller JH, Pasqualini R, Arap W. Combinatorial targeting and nanotechnology applications. Biomed Microdevices 2010;12:597-606. [PMID: 19669890 DOI: 10.1007/s10544-009-9340-6] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.2] [Reference Citation Analysis]
277 Niu W, Zhang Y, Ji K, Gu M, Gao P, Zhu D. Confirmation of top polymorphisms in hypertension genome wide association study among Han Chinese. Clinica Chimica Acta 2010;411:1491-5. [DOI: 10.1016/j.cca.2010.06.004] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 2.2] [Reference Citation Analysis]
278 Hossen MN, Kajimoto K, Akita H, Hyodo M, Ishitsuka T, Harashima H. Ligand-based targeted delivery of a peptide modified nanocarrier to endothelial cells in adipose tissue. Journal of Controlled Release 2010;147:261-8. [DOI: 10.1016/j.jconrel.2010.07.100] [Cited by in Crossref: 59] [Cited by in F6Publishing: 64] [Article Influence: 4.5] [Reference Citation Analysis]
279 Staquicini FI, Sidman RL, Arap W, Pasqualini R. Phage display technology for stem cell delivery and systemic therapy. Adv Drug Deliv Rev 2010;62:1213-6. [PMID: 20932865 DOI: 10.1016/j.addr.2010.09.014] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
280 Li ZJ, Wu WK, Ng SS, Yu L, Li HT, Wong CC, Wu YC, Zhang L, Ren SX, Sun XG, Chan KM, Cho CH. A novel peptide specifically targeting the vasculature of orthotopic colorectal cancer for imaging detection and drug delivery. J Control Release 2010;148:292-302. [PMID: 20854857 DOI: 10.1016/j.jconrel.2010.09.015] [Cited by in Crossref: 49] [Cited by in F6Publishing: 56] [Article Influence: 3.8] [Reference Citation Analysis]
281 Jones AT. Uptake and Intracellular Dynamics of Proteins Internalized by Cell-Penetrating Peptides. Organelle-Specific Pharmaceutical Nanotechnology 2010. [DOI: 10.1002/9780470875780.ch15] [Reference Citation Analysis]
282 Gonzalez AM, Leadbeater W, Podvin S, Borboa A, Burg M, Sawada R, Rayner J, Sims K, Terasaki T, Johanson C, Stopa E, Eliceiri B, Baird A. Epidermal growth factor targeting of bacteriophage to the choroid plexus for gene delivery to the central nervous system via cerebrospinal fluid. Brain Res 2010;1359:1-13. [PMID: 20732308 DOI: 10.1016/j.brainres.2010.08.044] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
283 Zahid M, Phillips BE, Albers SM, Giannoukakis N, Watkins SC, Robbins PD. Identification of a cardiac specific protein transduction domain by in vivo biopanning using a M13 phage peptide display library in mice. PLoS One 2010;5:e12252. [PMID: 20808875 DOI: 10.1371/journal.pone.0012252] [Cited by in Crossref: 53] [Cited by in F6Publishing: 54] [Article Influence: 4.1] [Reference Citation Analysis]
284 Kuadkitkan A, Wikan N, Fongsaran C, Smith DR. Identification and characterization of prohibitin as a receptor protein mediating DENV-2 entry into insect cells. Virology 2010;406:149-61. [PMID: 20674955 DOI: 10.1016/j.virol.2010.07.015] [Cited by in Crossref: 96] [Cited by in F6Publishing: 102] [Article Influence: 7.4] [Reference Citation Analysis]
285 Laakkonen P, Vuorinen K. Homing peptides as targeted delivery vehicles. Integr Biol (Camb) 2010;2:326-37. [PMID: 20657951 DOI: 10.1039/c0ib00013b] [Cited by in Crossref: 102] [Cited by in F6Publishing: 109] [Article Influence: 7.8] [Reference Citation Analysis]
286 Brown KC. Peptidic tumor targeting agents: the road from phage display peptide selections to clinical applications. Curr Pharm Des 2010;16:1040-54. [PMID: 20030617 DOI: 10.2174/138161210790963788] [Cited by in Crossref: 111] [Cited by in F6Publishing: 116] [Article Influence: 8.5] [Reference Citation Analysis]
287 Staquicini FI, Moeller BJ, Arap W, Pasqualini R. Combinatorial vascular targeting in translational medicine. Prot Clin Appl 2010;4:626-32. [DOI: 10.1002/prca.200900213] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
288 Ande SR, Mishra S. Palmitoylation of prohibitin at cysteine 69 facilitates its membrane translocation and interaction with Eps 15 homology domain protein 2 (EHD2). Biochem Cell Biol 2010;88:553-8. [DOI: 10.1139/o09-177] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
289 Tolppanen A, Kolehmainen M, Pulkkinen L, Uusitupa M. Tenomodulin gene and obesity-related phenotypes. Annals of Medicine 2010;42:265-75. [DOI: 10.3109/07853891003801123] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
290 de Kloet AD, Krause EG, Woods SC. The renin angiotensin system and the metabolic syndrome. Physiol Behav. 2010;100:525-534. [PMID: 20381510 DOI: 10.1016/j.physbeh.2010.03.018] [Cited by in Crossref: 126] [Cited by in F6Publishing: 135] [Article Influence: 9.7] [Reference Citation Analysis]
291 Ueberberg S, Ziegler D, Schechinger W, Dietrich JW, Akinturk S, Klein HH, Schneider S. In vitro phage display in a rat beta cell line: a simple approach for the generation of a single-chain antibody targeting a novel beta cell-specific epitope. Diabetologia 2010;53:1384-94. [PMID: 20369222 DOI: 10.1007/s00125-010-1725-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
292 Derda R, Musah S, Orner BP, Klim JR, Li L, Kiessling LL. High-throughput discovery of synthetic surfaces that support proliferation of pluripotent cells. J Am Chem Soc. 2010;132:1289-1295. [PMID: 20067240 DOI: 10.1021/ja906089g] [Cited by in Crossref: 115] [Cited by in F6Publishing: 120] [Article Influence: 8.8] [Reference Citation Analysis]
293 Barua S, Linton RS, Gamboa J, Banerjee I, Yarmush ML, Rege K. Lytic peptide-mediated sensitization of TRAIL-resistant prostate cancer cells to death receptor agonists. Cancer Lett 2010;293:240-53. [PMID: 20347216 DOI: 10.1016/j.canlet.2010.01.012] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
294 Bozaoglu K, Curran JE, Stocker CJ, Zaibi MS, Segal D, Konstantopoulos N, Morrison S, Carless M, Dyer TD, Cole SA, Goring HH, Moses EK, Walder K, Cawthorne MA, Blangero J, Jowett JB. Chemerin, a novel adipokine in the regulation of angiogenesis. J Clin Endocrinol Metab 2010;95:2476-85. [PMID: 20237162 DOI: 10.1210/jc.2010-0042] [Cited by in Crossref: 142] [Cited by in F6Publishing: 152] [Article Influence: 10.9] [Reference Citation Analysis]
295 Zeve D, Tang W, Graff J. Fighting fat with fat: the expanding field of adipose stem cells. Cell Stem Cell 2009;5:472-81. [PMID: 19896439 DOI: 10.1016/j.stem.2009.10.014] [Cited by in Crossref: 77] [Cited by in F6Publishing: 79] [Article Influence: 5.9] [Reference Citation Analysis]
296 Cao Y. Adipose tissue angiogenesis as a therapeutic target for obesity and metabolic diseases. Nat Rev Drug Discov. 2010;9:107-115. [PMID: 20118961 DOI: 10.1038/nrd3055] [Cited by in Crossref: 281] [Cited by in F6Publishing: 292] [Article Influence: 21.6] [Reference Citation Analysis]
297 Osman C, Merkwirth C, Langer T. Prohibitins and the functional compartmentalization of mitochondrial membranes. J Cell Sci 2009;122:3823-30. [PMID: 19889967 DOI: 10.1242/jcs.037655] [Cited by in Crossref: 219] [Cited by in F6Publishing: 233] [Article Influence: 16.8] [Reference Citation Analysis]
298 Lumeng CN. Adipose Tissue Macrophages: A Piece of the PAI of Metabolic Syndrome. Sci Transl Med 2010;2. [DOI: 10.1126/scitranslmed.3000850] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
299 Jayanna PK, Bedi D, Gillespie JW, DeInnocentes P, Wang T, Torchilin VP, Bird RC, Petrenko VA. Landscape phage fusion protein-mediated targeting of nanomedicines enhances their prostate tumor cell association and cytotoxic efficiency. Nanomedicine 2010;6:538-46. [PMID: 20138246 DOI: 10.1016/j.nano.2010.01.005] [Cited by in Crossref: 27] [Cited by in F6Publishing: 31] [Article Influence: 2.1] [Reference Citation Analysis]
300 Ueberberg S, Schneider S. Phage library-screening: A powerful approach for generation of targeting-agents specific for normal pancreatic islet-cells and islet-cell carcinoma in vivo. Regulatory Peptides 2010;160:1-8. [DOI: 10.1016/j.regpep.2009.11.017] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
301 Kim DH, Woods SC, Seeley RJ. Peptide designed to elicit apoptosis in adipose tissue endothelium reduces food intake and body weight. Diabetes 2010;59:907-15. [PMID: 20103704 DOI: 10.2337/db09-1141] [Cited by in Crossref: 47] [Cited by in F6Publishing: 48] [Article Influence: 3.6] [Reference Citation Analysis]
302 Patel N, Chatterjee SK, Vrbanac V, Chung I, Mu CJ, Olsen RR, Waghorne C, Zetter BR. Rescue of paclitaxel sensitivity by repression of Prohibitin1 in drug-resistant cancer cells. Proc Natl Acad Sci U S A 2010;107:2503-8. [PMID: 20133800 DOI: 10.1073/pnas.0910649107] [Cited by in Crossref: 78] [Cited by in F6Publishing: 81] [Article Influence: 6.0] [Reference Citation Analysis]
303 Michelfelder S, Trepel M. Adeno-associated viral vectors and their redirection to cell-type specific receptors. Adv Genet 2009;67:29-60. [PMID: 19914449 DOI: 10.1016/S0065-2660(09)67002-4] [Cited by in Crossref: 80] [Cited by in F6Publishing: 93] [Article Influence: 6.2] [Reference Citation Analysis]
304 Ravussin E, Smith SR. Role of the Adipocyte in Metabolism and Endocrine Function. Endocrinology 2010. [DOI: 10.1016/b978-1-4160-5583-9.00037-x] [Reference Citation Analysis]
305 Zahid M, Lu X, Mi Z, Robbins PD. Cationic and tissue-specific protein transduction domains identification, characterization, and therapeutic application. Adv Genet 2010;69:83-95. [PMID: 20807603 DOI: 10.1016/S0065-2660(10)69007-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
306 Dias-Neto E, Nunes DN, Giordano RJ, Sun J, Botz GH, Yang K, Setubal JC, Pasqualini R, Arap W. Next-generation phage display: integrating and comparing available molecular tools to enable cost-effective high-throughput analysis. PLoS One 2009;4:e8338. [PMID: 20020040 DOI: 10.1371/journal.pone.0008338] [Cited by in Crossref: 112] [Cited by in F6Publishing: 117] [Article Influence: 8.0] [Reference Citation Analysis]
307 Lee JH, Nguyen KH, Mishra S, Nyomba BL. Prohibitin is expressed in pancreatic beta-cells and protects against oxidative and proapoptotic effects of ethanol. FEBS J. 2010;277:488-500. [PMID: 20030709 DOI: 10.1111/j.1742-4658.2009.07505.x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 50] [Article Influence: 3.5] [Reference Citation Analysis]
308 Giordano RJ, Edwards JK, Tuder RM, Arap W, Pasqualini R. Combinatorial ligand-directed lung targeting. Proc Am Thorac Soc 2009;6:411-5. [PMID: 19687212 DOI: 10.1513/pats.200903-014AW] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 2.2] [Reference Citation Analysis]
309 Watkins CL, Brennan P, Fegan C, Takayama K, Nakase I, Futaki S, Jones AT. Cellular uptake, distribution and cytotoxicity of the hydrophobic cell penetrating peptide sequence PFVYLI linked to the proapoptotic domain peptide PAD. Journal of Controlled Release 2009;140:237-44. [DOI: 10.1016/j.jconrel.2009.04.028] [Cited by in Crossref: 53] [Cited by in F6Publishing: 50] [Article Influence: 3.8] [Reference Citation Analysis]
310 Meiliana A, Wijaya A. Adipose Tissue Biology: An Update Review. Indones Biomed J 2009;1:4. [DOI: 10.18585/inabj.v1i3.98] [Reference Citation Analysis]
311 Maekawa T, Jin W, Ishii S. The role of ATF-2 family transcription factors in adipocyte differentiation: antiobesity effects of p38 inhibitors. Mol Cell Biol 2010;30:613-25. [PMID: 19948881 DOI: 10.1128/MCB.00685-09] [Cited by in Crossref: 67] [Cited by in F6Publishing: 68] [Article Influence: 4.8] [Reference Citation Analysis]
312 Nie J, Sage EH. SPARC functions as an inhibitor of adipogenesis. J Cell Commun Signal 2009;3:247-54. [PMID: 19798596 DOI: 10.1007/s12079-009-0064-4] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 2.4] [Reference Citation Analysis]
313 Karalis KP, Giannogonas P, Kodela E, Koutmani Y, Zoumakis M, Teli T. Mechanisms of obesity and related pathology: linking immune responses to metabolic stress. FEBS J 2009;276:5747-54. [PMID: 19754872 DOI: 10.1111/j.1742-4658.2009.07304.x] [Cited by in Crossref: 98] [Cited by in F6Publishing: 106] [Article Influence: 7.0] [Reference Citation Analysis]
314 Artal-Sanz M, Tavernarakis N. Prohibitin and mitochondrial biology. Trends Endocrinol Metab 2009;20:394-401. [PMID: 19733482 DOI: 10.1016/j.tem.2009.04.004] [Cited by in Crossref: 197] [Cited by in F6Publishing: 207] [Article Influence: 14.1] [Reference Citation Analysis]
315 Theiss AL, Jenkins AK, Okoro NI, Klapproth JM, Merlin D, Sitaraman SV. Prohibitin inhibits tumor necrosis factor alpha-induced nuclear factor-kappa B nuclear translocation via the novel mechanism of decreasing importin alpha3 expression. Mol Biol Cell 2009;20:4412-23. [PMID: 19710421 DOI: 10.1091/mbc.e09-05-0361] [Cited by in Crossref: 54] [Cited by in F6Publishing: 57] [Article Influence: 3.9] [Reference Citation Analysis]
316 Christiaens V, Lijnen HR. Angiogenesis and development of adipose tissue. Mol Cell Endocrinol 2010;318:2-9. [PMID: 19686803 DOI: 10.1016/j.mce.2009.08.006] [Cited by in Crossref: 148] [Cited by in F6Publishing: 137] [Article Influence: 10.6] [Reference Citation Analysis]
317 Plutzky J. Expansion and contraction: the mighty, mighty fatty acid. Nat Med 2009;15:618-9. [PMID: 19498375 DOI: 10.1038/nm0609-618] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
318 Ueberberg S, Meier JJ, Waengler C, Schechinger W, Dietrich JW, Tannapfel A, Schmitz I, Schirrmacher R, Köller M, Klein HH, Schneider S. Generation of novel single-chain antibodies by phage-display technology to direct imaging agents highly selective to pancreatic beta- or alpha-cells in vivo. Diabetes 2009;58:2324-34. [PMID: 19592622 DOI: 10.2337/db09-0658] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 2.9] [Reference Citation Analysis]
319 Halberg N, Khan T, Trujillo ME, Wernstedt-Asterholm I, Attie AD, Sherwani S, Wang ZV, Landskroner-Eiger S, Dineen S, Magalang UJ, Brekken RA, Scherer PE. Hypoxia-inducible factor 1alpha induces fibrosis and insulin resistance in white adipose tissue. Mol Cell Biol. 2009;29:4467-4483. [PMID: 19546236 DOI: 10.1128/mcb.00192-09] [Cited by in Crossref: 586] [Cited by in F6Publishing: 614] [Article Influence: 41.9] [Reference Citation Analysis]
320 Sergeev IN, Li S, Ho C, Rawson NE, Dushenkov S. Polymethoxyflavones Activate Ca 2+ -Dependent Apoptotic Targets in Adipocytes. J Agric Food Chem 2009;57:5771-6. [DOI: 10.1021/jf901071k] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 1.9] [Reference Citation Analysis]
321 de Kloet AD, Krause EG, Kim DH, Sakai RR, Seeley RJ, Woods SC. The effect of angiotensin-converting enzyme inhibition using captopril on energy balance and glucose homeostasis. Endocrinology 2009;150:4114-23. [PMID: 19497971 DOI: 10.1210/en.2009-0065] [Cited by in Crossref: 58] [Cited by in F6Publishing: 62] [Article Influence: 4.1] [Reference Citation Analysis]
322 Ande SR, Gu Y, Nyomba BL, Mishra S. Insulin induced phosphorylation of prohibitin at tyrosine 114 recruits Shp1. Biochim Biophys Acta 2009;1793:1372-8. [PMID: 19497338 DOI: 10.1016/j.bbamcr.2009.05.008] [Cited by in Crossref: 50] [Cited by in F6Publishing: 52] [Article Influence: 3.6] [Reference Citation Analysis]
323 Zhang L, Reidy SP, Nicholson TE, Lee HJ, Majdalawieh A, Webber C, Stewart BR, Dolphin P, Ro HS. The role of AEBP1 in sex-specific diet-induced obesity. Mol Med 2005;11:39-47. [PMID: 16307171 DOI: 10.2119/2005-00021.Ro] [Cited by in Crossref: 13] [Cited by in F6Publishing: 23] [Article Influence: 0.9] [Reference Citation Analysis]
324 Zhang Y, Daquinag A, Traktuev DO, Amaya-Manzanares F, Simmons PJ, March KL, Pasqualini R, Arap W, Kolonin MG. White adipose tissue cells are recruited by experimental tumors and promote cancer progression in mouse models. Cancer Res. 2009;69:5259-5266. [PMID: 19491274 DOI: 10.1158/0008-5472.can-08-3444] [Cited by in Crossref: 235] [Cited by in F6Publishing: 245] [Article Influence: 16.8] [Reference Citation Analysis]
325 Michelfelder S, Kohlschütter J, Skorupa A, Pfennings S, Müller O, Kleinschmidt JA, Trepel M. Successful expansion but not complete restriction of tropism of adeno-associated virus by in vivo biopanning of random virus display peptide libraries. PLoS One 2009;4:e5122. [PMID: 19357785 DOI: 10.1371/journal.pone.0005122] [Cited by in Crossref: 60] [Cited by in F6Publishing: 61] [Article Influence: 4.3] [Reference Citation Analysis]
326 Tam J, Duda DG, Perentes JY, Quadri RS, Fukumura D, Jain RK. Blockade of VEGFR2 and not VEGFR1 can limit diet-induced fat tissue expansion: role of local versus bone marrow-derived endothelial cells. PLoS One 2009;4:e4974. [PMID: 19333381 DOI: 10.1371/journal.pone.0004974] [Cited by in Crossref: 64] [Cited by in F6Publishing: 71] [Article Influence: 4.6] [Reference Citation Analysis]
327 Binder M, Trepel M. Drugs targeting integrins for cancer therapy. Expert Opinion on Drug Discovery 2009;4:229-41. [DOI: 10.1517/17460440902751581] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
328 Lee DE, Kehlenbrink S, Lee H, Hawkins M, Yudkin JS. Getting the message across: mechanisms of physiological cross talk by adipose tissue. Am J Physiol Endocrinol Metab 2009;296:E1210-29. [PMID: 19258492 DOI: 10.1152/ajpendo.00015.2009] [Cited by in Crossref: 97] [Cited by in F6Publishing: 101] [Article Influence: 6.9] [Reference Citation Analysis]
329 Soares R. Angiogenesis in the Metabolic Syndrome. Oxidative Stress, Inflammation and Angiogenesis in the Metabolic Syndrome. [DOI: 10.1007/978-1-4020-9701-0_5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
330 Morciano M, Beckhaus T, Karas M, Zimmermann H, Volknandt W. The proteome of the presynaptic active zone: from docked synaptic vesicles to adhesion molecules and maxi-channels. J Neurochem 2009;108:662-75. [PMID: 19187093 DOI: 10.1111/j.1471-4159.2008.05824.x] [Cited by in Crossref: 71] [Cited by in F6Publishing: 76] [Article Influence: 5.1] [Reference Citation Analysis]
331 Ande SR, Moulik S, Mishra S. Interaction between O-GlcNAc modification and tyrosine phosphorylation of prohibitin: implication for a novel binary switch. PLoS One 2009;4:e4586. [PMID: 19238206 DOI: 10.1371/journal.pone.0004586] [Cited by in Crossref: 45] [Cited by in F6Publishing: 48] [Article Influence: 3.2] [Reference Citation Analysis]
332 Mintz PJ, Cardó-Vila M, Ozawa MG, Hajitou A, Rangel R, Guzman-Rojas L, Christianson DR, Arap MA, Giordano RJ, Souza GR, Easley J, Salameh A, Oliviero S, Brentani RR, Koivunen E, Arap W, Pasqualini R. An unrecognized extracellular function for an intracellular adapter protein released from the cytoplasm into the tumor microenvironment. Proc Natl Acad Sci U S A 2009;106:2182-7. [PMID: 19168626 DOI: 10.1073/pnas.0807543105] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 2.3] [Reference Citation Analysis]
333 Jain RK, Fukumura D. Angiogenesis in Development, Disease, and Regeneration. Strategies in Regenerative Medicine 2009. [DOI: 10.1007/978-0-387-74660-9_6] [Reference Citation Analysis]
334 Driessen WHP, Ozawa MG, Arap W, Pasqualini R. Ligand-directed cancer gene therapy to angiogenic vasculature. Adv Genet 2009;67:103-21. [PMID: 19914451 DOI: 10.1016/S0065-2660(09)67004-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
335 Kolonin MG. Tissue-Specific Targeting Based on Markers Expressed Outside Endothelial Cells. Tissue-Specific Vascular Endothelial Signals and Vector Targeting, Part A. Elsevier; 2009. pp. 61-102. [DOI: 10.1016/s0065-2660(09)67003-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
336 Ye J. Emerging role of adipose tissue hypoxia in obesity and insulin resistance. Int J Obes (Lond). 2009;33:54-66. [PMID: 19050672 DOI: 10.1038/ijo.2008.229] [Cited by in Crossref: 366] [Cited by in F6Publishing: 390] [Article Influence: 24.4] [Reference Citation Analysis]
337 Lee J, Saha PK, Yang QH, Lee S, Park JY, Suh Y, Lee SK, Chan L, Roeder RG, Lee JW. Targeted inactivation of MLL3 histone H3-Lys-4 methyltransferase activity in the mouse reveals vital roles for MLL3 in adipogenesis. Proc Natl Acad Sci U S A 2008;105:19229-34. [PMID: 19047629 DOI: 10.1073/pnas.0810100105] [Cited by in Crossref: 140] [Cited by in F6Publishing: 143] [Article Influence: 9.3] [Reference Citation Analysis]
338 Fukumura D, Jain RK. Imaging angiogenesis and the microenvironment. APMIS 2008;116:695-715. [PMID: 18834413 DOI: 10.1111/j.1600-0463.2008.01148.x] [Cited by in Crossref: 116] [Cited by in F6Publishing: 123] [Article Influence: 7.7] [Reference Citation Analysis]
339 Staquicini FI, Tandle A, Libutti SK, Sun J, Zigler M, Bar-Eli M, Aliperti F, Pérez EC, Gershenwald JE, Mariano M. A subset of host B lymphocytes controls melanoma metastasis through a melanoma cell adhesion molecule/MUC18-dependent interaction: evidence from mice and humans. Cancer Res. 2008;68:8419-8428. [PMID: 18922915 DOI: 10.1158/0008-5472.can-08-1242] [Cited by in Crossref: 57] [Cited by in F6Publishing: 59] [Article Influence: 3.8] [Reference Citation Analysis]
340 Halberg N, Wernstedt-Asterholm I, Scherer PE. The adipocyte as an endocrine cell. Endocrinol Metab Clin North Am 2008;37:753-68, x-xi. [PMID: 18775362 DOI: 10.1016/j.ecl.2008.07.002] [Cited by in Crossref: 269] [Cited by in F6Publishing: 298] [Article Influence: 17.9] [Reference Citation Analysis]
341 Yang Yu, Zizheng Wang, Tongxin Du. Mouse Thymus Targeted Peptide Isolated by In Vivo Phage Display Can Inhibit Bioactivity of Thymus Output In Vivo. J Biomol Screen 2008;13:968-74. [DOI: 10.1177/1087057108326537] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
342 Ellerby HM, Bredesen DE, Fujimura S, John V. Hunter-killer peptide (HKP) for targeted therapy. J Med Chem 2008;51:5887-92. [PMID: 18828573 DOI: 10.1021/jm800495u] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 1.7] [Reference Citation Analysis]
343 Kohlschütter J, Michelfelder S, Trepel M. Drug delivery in acute myeloid leukemia. Expert Opin Drug Deliv 2008;5:653-63. [PMID: 18532921 DOI: 10.1517/17425247.5.6.653] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
344 Cardó-Vila M, Zurita AJ, Giordano RJ, Sun J, Rangel R, Guzman-Rojas L, Anobom CD, Valente AP, Almeida FC, Lahdenranta J, Kolonin MG, Arap W, Pasqualini R. A ligand peptide motif selected from a cancer patient is a receptor-interacting site within human interleukin-11. PLoS One 2008;3:e3452. [PMID: 18941632 DOI: 10.1371/journal.pone.0003452] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 1.9] [Reference Citation Analysis]
345 Ozawa MG, Zurita AJ, Dias-Neto E, Nunes DN, Sidman RL, Gelovani JG, Arap W, Pasqualini R. Beyond receptor expression levels: the relevance of target accessibility in ligand-directed pharmacodelivery systems. Trends Cardiovasc Med 2008;18:126-32. [PMID: 18555185 DOI: 10.1016/j.tcm.2008.03.001] [Cited by in Crossref: 37] [Cited by in F6Publishing: 28] [Article Influence: 2.5] [Reference Citation Analysis]
346 Ledoux S, Queguiner I, Msika S, Calderari S, Rufat P, Gasc JM, Corvol P, Larger E. Angiogenesis associated with visceral and subcutaneous adipose tissue in severe human obesity. Diabetes 2008;57:3247-57. [PMID: 18835936 DOI: 10.2337/db07-1812] [Cited by in Crossref: 85] [Cited by in F6Publishing: 88] [Article Influence: 5.7] [Reference Citation Analysis]
347 Tang W, Zeve D, Suh JM, Bosnakovski D, Kyba M, Hammer RE, Tallquist MD, Graff JM. White fat progenitor cells reside in the adipose vasculature. Science. 2008;322:583-586. [PMID: 18801968 DOI: 10.1126/science.1156232] [Cited by in Crossref: 814] [Cited by in F6Publishing: 840] [Article Influence: 54.3] [Reference Citation Analysis]
348 Giordano RJ, Lahdenranta J, Zhen L, Chukwueke U, Petrache I, Langley RR, Fidler IJ, Pasqualini R, Tuder RM, Arap W. Targeted induction of lung endothelial cell apoptosis causes emphysema-like changes in the mouse. J Biol Chem 2008;283:29447-60. [PMID: 18718906 DOI: 10.1074/jbc.M804595200] [Cited by in Crossref: 88] [Cited by in F6Publishing: 96] [Article Influence: 5.9] [Reference Citation Analysis]
349 Harvey NL. The link between lymphatic function and adipose biology. Ann N Y Acad Sci. 2008;1131:82-88. [PMID: 18519961 DOI: 10.1196/annals.1413.007] [Cited by in Crossref: 79] [Cited by in F6Publishing: 80] [Article Influence: 5.3] [Reference Citation Analysis]
350 Nie J, Chang B, Traktuev DO, Sun J, March K, Chan L, Sage EH, Pasqualini R, Arap W, Kolonin MG. IFATS collection: Combinatorial peptides identify alpha5beta1 integrin as a receptor for the matricellular protein SPARC on adipose stromal cells. Stem Cells 2008;26:2735-45. [PMID: 18583538 DOI: 10.1634/stemcells.2008-0212] [Cited by in Crossref: 62] [Cited by in F6Publishing: 63] [Article Influence: 4.1] [Reference Citation Analysis]
351 Della-fera MA, Hamrick MW, Baile CA. Central nervous system controls of adipose tissue apoptosis. Neurobiology of Obesity 2008. [DOI: 10.1017/cbo9780511541643.011] [Reference Citation Analysis]
352 Merkwirth C, Langer T. Prohibitin function within mitochondria: essential roles for cell proliferation and cristae morphogenesis. Biochim Biophys Acta 2009;1793:27-32. [PMID: 18558096 DOI: 10.1016/j.bbamcr.2008.05.013] [Cited by in Crossref: 276] [Cited by in F6Publishing: 297] [Article Influence: 18.4] [Reference Citation Analysis]
353 Wang P, Mariman E, Renes J, Keijer J. The secretory function of adipocytes in the physiology of white adipose tissue. J Cell Physiol 2008;216:3-13. [PMID: 18264975 DOI: 10.1002/jcp.21386] [Cited by in Crossref: 211] [Cited by in F6Publishing: 222] [Article Influence: 14.1] [Reference Citation Analysis]
354 Lanoix J, Paramithiotis E. Secretory vesicle analysis for discovery of low abundance plasma biomarkers. Expert Opinion on Medical Diagnostics 2008;2:475-85. [DOI: 10.1517/17530059.2.5.475] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
355 Van Langendonckt A, Donnez J, Defrere S, Dunselman GA, Groothuis PG. Antiangiogenic and vascular-disrupting agents in endometriosis: pitfalls and promises. Molecular Human Reproduction 2008;14:259-68. [DOI: 10.1093/molehr/gan019] [Cited by in Crossref: 46] [Cited by in F6Publishing: 48] [Article Influence: 3.1] [Reference Citation Analysis]
356 Nishimura S, Takahashi S, Kamikatahira H, Kuroki Y, Jaalouk DE, O'Brien S, Koivunen E, Arap W, Pasqualini R, Nakayama H, Kuniyasu A. Combinatorial targeting of the macropinocytotic pathway in leukemia and lymphoma cells. J Biol Chem 2008;283:11752-62. [PMID: 18292083 DOI: 10.1074/jbc.M708849200] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 2.7] [Reference Citation Analysis]
357 Rayalam S, Della-Fera MA, Krieg PA, Cox CM, Robins A, Baile CA. A putative role for apelin in the etiology of obesity. Biochem Biophys Res Commun. 2008;368:815-819. [PMID: 18275845 DOI: 10.1016/j.bbrc.2008.02.008] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 2.3] [Reference Citation Analysis]
358 Oi J, Terashima T, Kojima H, Fujimiya M, Maeda K, Arai R, Chan L, Yasuda H, Kashiwagi A, Kimura H. Isolation of specific peptides that home to dorsal root ganglion neurons in mice. Neurosci Lett 2008;434:266-72. [PMID: 18329804 DOI: 10.1016/j.neulet.2008.01.062] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
359 Ross JA, Nagy ZS, Kirken RA. The PHB1/2 Phosphocomplex Is Required for Mitochondrial Homeostasis and Survival of Human T Cells. Journal of Biological Chemistry 2008;283:4699-713. [DOI: 10.1074/jbc.m708232200] [Cited by in Crossref: 69] [Cited by in F6Publishing: 71] [Article Influence: 4.6] [Reference Citation Analysis]
360 Henke E, Perk J, Vider J, de Candia P, Chin Y, Solit DB, Ponomarev V, Cartegni L, Manova K, Rosen N, Benezra R. Peptide-conjugated antisense oligonucleotides for targeted inhibition of a transcriptional regulator in vivo. Nat Biotechnol 2008;26:91-100. [PMID: 18176556 DOI: 10.1038/nbt1366] [Cited by in Crossref: 91] [Cited by in F6Publishing: 91] [Article Influence: 6.1] [Reference Citation Analysis]
361 Griffin NM, Schnitzer JE. Chapter 8 Proteomic Mapping of the Vascular Endothelium In Vivo for Vascular Targeting. Angiogenesis: In Vivo Systems, Part B. Elsevier; 2008. pp. 177-208. [DOI: 10.1016/s0076-6879(08)03008-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
362 Trepel M, Pasqualini R, Arap W. Chapter 4 Screening Phage‐Display Peptide Libraries for Vascular Targeted Peptides. Angiogenesis: In Vivo Systems, Part B 2008. [DOI: 10.1016/s0076-6879(08)03004-8] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 1.0] [Reference Citation Analysis]
363 Kamikawa A, Ishii T, Shimada K, Makondo K, Inanami O, Sakane N, Yoshida T, Saito M, Kimura K. Proinsulin C-peptide abrogates type-1 diabetes-induced increase of renal endothelial nitric oxide synthase in rats. Diabetes Metab Res Rev 2008;24:331-8. [DOI: 10.1002/dmrr.810] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 1.8] [Reference Citation Analysis]
364 Winter A, Kämäräinen O, Hofmann A. Molecular modeling of prohibitin domains. Proteins 2007;68:353-62. [PMID: 17427253 DOI: 10.1002/prot.21355] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 2.1] [Reference Citation Analysis]
365 Bell LN, Cai L, Johnstone BH, Traktuev DO, March KL, Considine RV. A central role for hepatocyte growth factor in adipose tissue angiogenesis. Am J Physiol Endocrinol Metab 2008;294:E336-44. [PMID: 18073323 DOI: 10.1152/ajpendo.00272.2007] [Cited by in Crossref: 54] [Cited by in F6Publishing: 54] [Article Influence: 3.4] [Reference Citation Analysis]
366 Sandoval CM, Salzameda B, Reyes K, Williams T, Hohman VS, Plesniak LA. Anti-obesity and anti-tumor pro-apoptotic peptides are sufficient to cause release of cytochrome c from vesicles. FEBS Lett 2007;581:5464-8. [PMID: 17983599 DOI: 10.1016/j.febslet.2007.10.051] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
367 Traktuev DO, Merfeld-Clauss S, Li J, Kolonin M, Arap W, Pasqualini R, Johnstone BH, March KL. A population of multipotent CD34-positive adipose stromal cells share pericyte and mesenchymal surface markers, reside in a periendothelial location, and stabilize endothelial networks. Circ Res. 2008;102:77-85. [PMID: 17967785 DOI: 10.1161/circresaha.107.159475] [Cited by in Crossref: 638] [Cited by in F6Publishing: 667] [Article Influence: 39.9] [Reference Citation Analysis]
368 He B, Feng Q, Mukherjee A, Lonard DM, DeMayo FJ, Katzenellenbogen BS, Lydon JP, O'Malley BW. A repressive role for prohibitin in estrogen signaling. Mol Endocrinol 2008;22:344-60. [PMID: 17932104 DOI: 10.1210/me.2007-0400] [Cited by in Crossref: 96] [Cited by in F6Publishing: 101] [Article Influence: 6.0] [Reference Citation Analysis]
369 Sengenès C, Miranville A, Lolmède K, Curat CA, Bouloumié A. The role of endothelial cells in inflamed adipose tissue. J Intern Med 2007;262:415-21. [DOI: 10.1111/j.1365-2796.2007.01853.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 1.9] [Reference Citation Analysis]
370 Grant CV, Sit SL, De Angelis AA, Khuong KS, Wu CH, Plesniak LA, Opella SJ. An efficient (1)H/(31)P double-resonance solid-state NMR probe that utilizes a scroll coil. J Magn Reson 2007;188:279-84. [PMID: 17719813 DOI: 10.1016/j.jmr.2007.06.016] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.3] [Reference Citation Analysis]
371 Tolppanen AM, Pulkkinen L, Kolehmainen M, Schwab U, Lindström J, Tuomilehto J, Uusitupa M; Finnish Diabetes Prevention Study Group. Tenomodulin is associated with obesity and diabetes risk: the Finnish diabetes prevention study. Obesity (Silver Spring) 2007;15:1082-8. [PMID: 17495183 DOI: 10.1038/oby.2007.613] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.4] [Reference Citation Analysis]
372 Hajitou A, Rangel R, Trepel M, Soghomonyan S, Gelovani JG, Alauddin MM, Pasqualini R, Arap W. Design and construction of targeted AAVP vectors for mammalian cell transduction. Nat Protoc 2007;2:523-31. [PMID: 17406616 DOI: 10.1038/nprot.2007.51] [Cited by in Crossref: 75] [Cited by in F6Publishing: 76] [Article Influence: 4.7] [Reference Citation Analysis]
373 Roche R, Hoareau L, Mounet F, Festy F. Adult stem cells for cardiovascular diseases: the adipose tissue potential. Expert Opin Biol Ther 2007;7:791-8. [PMID: 17555365 DOI: 10.1517/14712598.7.6.791] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
374 Denby L, Work LM, Seggern DJ, Wu E, McVey JH, Nicklin SA, Baker AH. Development of renal-targeted vectors through combined in vivo phage display and capsid engineering of adenoviral fibers from serotype 19p. Mol Ther 2007;15:1647-54. [PMID: 17551506 DOI: 10.1038/sj.mt.6300214] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 2.1] [Reference Citation Analysis]
375 Cooke PS, Holsberger DR, Cimafranca MA, Meling DD, Beals CM, Nakayama K, Nakayama KI, Kiyokawa H. The F Box Protein S Phase Kinase-associated Protein 2 Regulates Adipose Mass and Adipocyte Number in Vivo*. Obesity 2007;15:1400-8. [DOI: 10.1038/oby.2007.168] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
376 Lahdenranta J, Sidman RL, Pasqualini R, Arap W. Treatment of hypoxia‐induced retinopathy with targeted proapoptotic peptidomimetic in a mouse model of disease. FASEB j 2007;21:3272-8. [DOI: 10.1096/fj.07-8273com] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.4] [Reference Citation Analysis]
377 Folkman J. Angiogenesis: an organizing principle for drug discovery? Nat Rev Drug Discov. 2007;6:273-286. [PMID: 17396134 DOI: 10.1038/nrd2115] [Cited by in Crossref: 1632] [Cited by in F6Publishing: 1724] [Article Influence: 102.0] [Reference Citation Analysis]
378 Ro HS, Zhang L, Majdalawieh A, Kim SW, Wu X, Lyons PJ, Webber C, Ma H, Reidy SP, Boudreau A, Miller JR, Mitchell P, McLeod RS. Adipocyte enhancer-binding protein 1 modulates adiposity and energy homeostasis. Obesity (Silver Spring) 2007;15:288-302. [PMID: 17299101 DOI: 10.1038/oby.2007.569] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 1.9] [Reference Citation Analysis]
379 Costa C, Incio J, Soares R. Angiogenesis and chronic inflammation: cause or consequence? Angiogenesis 2007;10:149-66. [PMID: 17457680 DOI: 10.1007/s10456-007-9074-0] [Cited by in Crossref: 310] [Cited by in F6Publishing: 321] [Article Influence: 19.4] [Reference Citation Analysis]
380 Balestrieri ML, Napoli C. Novel challenges in exploring peptide ligands and corresponding tissue-specific endothelial receptors. Eur J Cancer 2007;43:1242-50. [PMID: 17449238 DOI: 10.1016/j.ejca.2007.02.006] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 1.8] [Reference Citation Analysis]
381 Jäger S, Jahnke A, Wilmes T, Adebahr S, Vögtle FN, Delima-Hahn E, Pfeifer D, Berg T, Lübbert M, Trepel M. Leukemia-targeting ligands isolated from phage-display peptide libraries. Leukemia. 2007;21:411-420. [PMID: 17252013 DOI: 10.1038/sj.leu.2404548] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 1.6] [Reference Citation Analysis]
382 Sergeeva A, Kolonin MG, Molldrem JJ, Pasqualini R, Arap W. Display technologies: application for the discovery of drug and gene delivery agents. Adv Drug Deliv Rev 2006;58:1622-54. [PMID: 17123658 DOI: 10.1016/j.addr.2006.09.018] [Cited by in Crossref: 179] [Cited by in F6Publishing: 185] [Article Influence: 10.5] [Reference Citation Analysis]
383 Tuder RM, Yoshida T, Arap W, Pasqualini R, Petrache I. State of the art. Cellular and molecular mechanisms of alveolar destruction in emphysema: an evolutionary perspective. Proc Am Thorac Soc 2006;3:503-10. [PMID: 16921129 DOI: 10.1513/pats.200603-054MS] [Cited by in Crossref: 121] [Cited by in F6Publishing: 133] [Article Influence: 7.1] [Reference Citation Analysis]
384 Mishra S, Moulik S, Murphy LJ. Prohibitin binds to C3 and enhances complement activation. Mol Immunol 2007;44:1897-902. [PMID: 17070910 DOI: 10.1016/j.molimm.2006.09.025] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 0.6] [Reference Citation Analysis]
385 Hajitou A, Pasqualini R, Arap W. Vascular targeting: recent advances and therapeutic perspectives. Trends Cardiovasc Med 2006;16:80-8. [PMID: 16546688 DOI: 10.1016/j.tcm.2006.01.003] [Cited by in Crossref: 116] [Cited by in F6Publishing: 119] [Article Influence: 6.8] [Reference Citation Analysis]
386 Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest. 2006;116:1793-1801. [PMID: 16823477 DOI: 10.1172/jci29069] [Cited by in Crossref: 2726] [Cited by in F6Publishing: 2886] [Article Influence: 160.4] [Reference Citation Analysis]
387 Fantin VR, Leder P. Mitochondriotoxic compounds for cancer therapy. Oncogene 2006;25:4787-97. [PMID: 16892091 DOI: 10.1038/sj.onc.1209599] [Cited by in Crossref: 111] [Cited by in F6Publishing: 115] [Article Influence: 6.5] [Reference Citation Analysis]
388 Mishra S, Murphy LC, Murphy LJ. The Prohibitins: emerging roles in diverse functions. J Cell Mol Med 2006;10:353-63. [PMID: 16796804 DOI: 10.1111/j.1582-4934.2006.tb00404.x] [Cited by in Crossref: 207] [Cited by in F6Publishing: 220] [Article Influence: 12.2] [Reference Citation Analysis]
389 German AJ. The Growing Problem of Obesity in Dogs and Cats. The Journal of Nutrition 2006;136:1940S-6S. [DOI: 10.1093/jn/136.7.1940s] [Cited by in Crossref: 453] [Cited by in F6Publishing: 467] [Article Influence: 26.6] [Reference Citation Analysis]
390 Rastogi S, Joshi B, Dasgupta P, Morris M, Wright K, Chellappan S. Prohibitin facilitates cellular senescence by recruiting specific corepressors to inhibit E2F target genes. Mol Cell Biol 2006;26:4161-71. [PMID: 16705168 DOI: 10.1128/MCB.02142-05] [Cited by in Crossref: 66] [Cited by in F6Publishing: 73] [Article Influence: 3.9] [Reference Citation Analysis]
391 Sandoval CM, Geierstanger BH, Fujimura S, Balatbat C, Williams T, de Unamuno J, Whiles-lillig JA, Ellerby LM, Michael Ellerby H, Jennings P, Plesniak LA. Structural Evaluation of a Novel Pro-apoptotic Peptide Coupled to CNGRC Tumor Homing Sequence by NMR. Chemical Biology & Drug Design 2006;67:417-24. [DOI: 10.1111/j.1747-0285.2006.00394.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
392 Shimokawa K, Mashima I, Asai A, Yamada K, Kita M, Uemura D. (−)-Ternatin, a highly N-methylated cyclic heptapeptide that inhibits fat accumulation: structure and synthesis. Tetrahedron Letters 2006;47:4445-8. [DOI: 10.1016/j.tetlet.2006.04.073] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 1.6] [Reference Citation Analysis]
393 Work LM, Büning H, Hunt E, Nicklin SA, Denby L, Britton N, Leike K, Odenthal M, Drebber U, Hallek M, Baker AH. Vascular bed-targeted in vivo gene delivery using tropism-modified adeno-associated viruses. Molecular Therapy 2006;13:683-93. [DOI: 10.1016/j.ymthe.2005.11.013] [Cited by in Crossref: 100] [Cited by in F6Publishing: 103] [Article Influence: 5.9] [Reference Citation Analysis]
394 Kolonin MG, Sun J, Do KA, Vidal CI, Ji Y, Baggerly KA, Pasqualini R, Arap W. Synchronous selection of homing peptides for multiple tissues by in vivo phage display. FASEB J. 2006;20:979-981. [PMID: 16581960 DOI: 10.1096/fj.05-5186fje] [Cited by in Crossref: 100] [Cited by in F6Publishing: 104] [Article Influence: 5.9] [Reference Citation Analysis]
395 Oh Y, Mohiuddin I, Sun Y, Putnam JB Jr, Hong WK, Arap W, Pasqualini R. Phenotypic diversity of the lung vasculature in experimental models of metastases. Chest 2005;128:596S-600S. [PMID: 16373855 DOI: 10.1378/chest.128.6_suppl.596S] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]
396 Vessal M, Mishra S, Moulik S, Murphy LJ. Prohibitin attenuates insulin-stimulated glucose and fatty acid oxidation in adipose tissue by inhibition of pyruvate carboxylase. FEBS Journal 2006;273:568-76. [DOI: 10.1111/j.1742-4658.2005.05090.x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 48] [Article Influence: 2.8] [Reference Citation Analysis]
397 Kim H, Nelson-dooley C, Della-fera MA, Yang J, Zhang W, Duan J, Hartzell DL, Hamrick MW, Baile CA. Genistein Decreases Food Intake, Body Weight, and Fat Pad Weight and Causes Adipose Tissue Apoptosis in Ovariectomized Female Mice. The Journal of Nutrition 2006;136:409-14. [DOI: 10.1093/jn/136.2.409] [Cited by in Crossref: 142] [Cited by in F6Publishing: 149] [Article Influence: 8.4] [Reference Citation Analysis]
398 Souza GR, Christianson DR, Staquicini FI, Ozawa MG, Snyder EY, Sidman RL, Miller JH, Arap W, Pasqualini R. Networks of gold nanoparticles and bacteriophage as biological sensors and cell-targeting agents. Proc Natl Acad Sci U S A 2006;103:1215-20. [PMID: 16434473 DOI: 10.1073/pnas.0509739103] [Cited by in Crossref: 204] [Cited by in F6Publishing: 212] [Article Influence: 12.0] [Reference Citation Analysis]
399 Jackson M, Ahima R. Neuroendocrine and metabolic effects of adipocyte-derived hormones. Clinical Science 2006;110:143-52. [DOI: 10.1042/cs20050243] [Cited by in Crossref: 47] [Cited by in F6Publishing: 48] [Article Influence: 2.8] [Reference Citation Analysis]
400 Kehoe JW, Kay BK. Filamentous phage display in the new millennium. Chem Rev. 2005;105:4056-4072. [PMID: 16277371 DOI: 10.1021/cr000261r] [Cited by in Crossref: 302] [Cited by in F6Publishing: 311] [Article Influence: 17.8] [Reference Citation Analysis]
401 Fukuda MN. Screening of peptide-displaying phage libraries to identify short peptides mimicking carbohydrates. Methods Enzymol 2006;416:51-60. [PMID: 17113859 DOI: 10.1016/S0076-6879(06)16004-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
402 Mcmahon K, Zhu M, Kwon SW, Liu P, Zhao Y, Anderson RGW. Detergent-free caveolae proteome suggests an interaction with ER and mitochondria. Proteomics 2006;6:143-52. [DOI: 10.1002/pmic.200500208] [Cited by in Crossref: 55] [Cited by in F6Publishing: 56] [Article Influence: 3.2] [Reference Citation Analysis]
403 Perera RJ, Marcusson EG, Koo S, Kang X, Kim Y, White N, Dean NM. Identification of novel PPARgamma target genes in primary human adipocytes. Gene 2006;369:90-9. [PMID: 16380219 DOI: 10.1016/j.gene.2005.10.021] [Cited by in Crossref: 46] [Cited by in F6Publishing: 47] [Article Influence: 2.6] [Reference Citation Analysis]
404 Lionakis MS, Lahdenranta J, Sun J, Liu W, Lewis RE, Albert ND, Pasqualini R, Arap W, Kontoyiannis DP. Development of a ligand-directed approach to study the pathogenesis of invasive aspergillosis. Infect Immun 2005;73:7747-58. [PMID: 16239579 DOI: 10.1128/IAI.73.11.7747-7758.2005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
405 Borghouts C, Kunz C, Groner B. Peptide aptamers: recent developments for cancer therapy. Expert Opinion on Biological Therapy 2005;5:783-97. [DOI: 10.1517/14712598.5.6.783] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 1.7] [Reference Citation Analysis]
406 Klein J, Perwitz N, Kraus D, Fasshauer M. Adipose tissue as source and target for novel therapies. Trends Endocrinol Metab. 2006;17:26-32. [PMID: 16309918 DOI: 10.1016/j.tem.2005.11.008] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 2.1] [Reference Citation Analysis]
407 Nawrocki AR, Scherer PE. Keynote review: the adipocyte as a drug discovery target. Drug Discov Today 2005;10:1219-30. [PMID: 16213414 DOI: 10.1016/S1359-6446(05)03569-5] [Cited by in Crossref: 121] [Cited by in F6Publishing: 98] [Article Influence: 6.7] [Reference Citation Analysis]
408 Mishra S, Murphy LC, Nyomba BL, Murphy LJ. Prohibitin: a potential target for new therapeutics. Trends Mol Med 2005;11:192-7. [PMID: 15823758 DOI: 10.1016/j.molmed.2005.02.004] [Cited by in Crossref: 170] [Cited by in F6Publishing: 179] [Article Influence: 9.4] [Reference Citation Analysis]
409 Oike Y, Akao M, Kubota Y, Suda T. Angiopoietin-like proteins: potential new targets for metabolic syndrome therapy. Trends Mol Med 2005;11:473-9. [PMID: 16154386 DOI: 10.1016/j.molmed.2005.08.002] [Cited by in Crossref: 101] [Cited by in F6Publishing: 92] [Article Influence: 5.6] [Reference Citation Analysis]
410 Zhang L, Hoffman JA, Ruoslahti E. Molecular profiling of heart endothelial cells. Circulation 2005;112:1601-11. [PMID: 16144998 DOI: 10.1161/CIRCULATIONAHA.104.529537] [Cited by in Crossref: 75] [Cited by in F6Publishing: 78] [Article Influence: 4.2] [Reference Citation Analysis]
411 Rajalingam K, Wunder C, Brinkmann V, Churin Y, Hekman M, Sievers C, Rapp UR, Rudel T. Prohibitin is required for Ras-induced Raf–MEK–ERK activation and epithelial cell migration. Nat Cell Biol 2005;7:837-43. [DOI: 10.1038/ncb1283] [Cited by in Crossref: 265] [Cited by in F6Publishing: 275] [Article Influence: 14.7] [Reference Citation Analysis]
412 Morrow IC, Parton RG. Flotillins and the PHB Domain Protein Family: Rafts, Worms and Anaesthetics: Flotillins and the PHB Family. Traffic 2005;6:725-40. [DOI: 10.1111/j.1600-0854.2005.00318.x] [Cited by in Crossref: 209] [Cited by in F6Publishing: 215] [Article Influence: 11.6] [Reference Citation Analysis]
413 Arap MA. Phage display technology: applications and innovations. Genet Mol Biol 2005;28:1-9. [DOI: 10.1590/s1415-47572005000100001] [Cited by in Crossref: 63] [Cited by in F6Publishing: 63] [Article Influence: 3.5] [Reference Citation Analysis]
414 Lahdenranta J, Arap W, Pasqualini R. The Use of Proteomics to Map Phenotypic Heterogeneity of the Endothelium. Endothelial Cells in Health and Disease 2005. [DOI: 10.3109/9780203025956-6] [Reference Citation Analysis]
415 Plesniak LA, Parducho JI, Ziebart A, Geierstanger BH, Whiles JA, Melacini G, Jennings PA. Orientation and helical conformation of a tissue-specific hunter-killer peptide in micelles. Protein Sci 2004;13:1988-96. [PMID: 15273301 DOI: 10.1110/ps.04853204] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
416 Brown KC. Hitting the target with bifunctional phage. Chem Biol 2004;11:1033-5. [PMID: 15324803 DOI: 10.1016/j.chembiol.2004.08.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
417 Karathanasis SK, Schiebinger RJ. Drug Treatment in the Metabolic Syndrome. The Metabolic Syndrome at the Beginning of the XXI Century 2005. [DOI: 10.1016/b978-84-8174-892-5.50027-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
418 Arap MA, Lahdenranta J, Mintz PJ, Hajitou A, Sarkis AS, Arap W, Pasqualini R. Cell surface expression of the stress response chaperone GRP78 enables tumor targeting by circulating ligands. Cancer Cell 2004;6:275-84. [PMID: 15380518 DOI: 10.1016/j.ccr.2004.08.018] [Cited by in Crossref: 311] [Cited by in F6Publishing: 323] [Article Influence: 16.4] [Reference Citation Analysis]
419 Naaz A, Holsberger DR, Iwamoto GA, Nelson A, Kiyokawa H, Cooke PS. Loss of cyclin-dependent kinase inhibitors produces adipocyte hyperplasia and obesity. FASEB J 2004;18:1925-7. [PMID: 15469964 DOI: 10.1096/fj.04-2631fje] [Cited by in Crossref: 116] [Cited by in F6Publishing: 118] [Article Influence: 6.1] [Reference Citation Analysis]
420 Cheung HH, Noble C, Hooft R, Collin M. Monitor – Biology. Drug Discovery Today 2004;9:621-622. [DOI: 10.1016/s1359-6446(04)03155-1] [Reference Citation Analysis]
421 Reitman ML. Magic bullets melt fat. Nat Med 2004;10:581-2. [DOI: 10.1038/nm0604-581] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
422 Neumann N. Mice fight the flab. Nature 2004. [DOI: 10.1038/news040503-14] [Reference Citation Analysis]
423 [DOI: 10.1101/2020.03.24.997536] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Reference Citation Analysis]